patientid,line_of_therapy,initial_regimen,final_regimen,line_start_date,line_end_date,duration_days,num_administrations,num_regimen_changes,drugs_used,regimen_evolution
1,1,5-fluorouracil,5-fluorouracil,2023-01-01,2023-03-07,65,6,0,5-fluorouracil,"[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-07 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}]"
2,1,capecitabine,5-fluorouracil+capecitabine+encorafenib+oxaliplatin,2023-01-01,2023-03-11,69,18,3,"5-fluorouracil, capecitabine, encorafenib, oxaliplatin","[{('regimen', ''): '5-fluorouracil+capecitabine+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-11 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-31 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
2,2,aflibercept,aflibercept+capecitabine+encorafenib+oxaliplatin,2023-03-11,2023-04-14,34,7,3,"aflibercept, capecitabine, encorafenib, oxaliplatin","[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-03-11 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-11 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'aflibercept+capecitabine', ('administratedate', 'min'): Timestamp('2023-03-24 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-24 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'aflibercept+capecitabine+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-03-24 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-14 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'aflibercept+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-03-24 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-24 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
2,3,cetuximab,5-fluorouracil+capecitabine+cetuximab+encorafenib+oxaliplatin,2023-04-14,2023-05-22,38,7,4,"5-fluorouracil, capecitabine, cetuximab, encorafenib, oxaliplatin","[{('regimen', ''): '5-fluorouracil+capecitabine+cetuximab+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-22 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+cetuximab+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-04-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-27 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-04-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-14 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'cetuximab+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-04-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-27 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'cetuximab+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-04-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-27 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
2,4,regorafenib,5-fluorouracil+capecitabine+encorafenib+oxaliplatin+regorafenib,2023-05-22,2024-01-17,240,14,4,"5-fluorouracil, capecitabine, encorafenib, oxaliplatin, regorafenib","[{('regimen', ''): '5-fluorouracil+capecitabine+encorafenib+oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2023-07-30 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-17 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine+encorafenib+oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2023-06-11 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-11 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2023-06-11 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-11 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+regorafenib', ('administratedate', 'min'): Timestamp('2023-06-11 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-11 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-05-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-22 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
2,5,nivolumab,5-fluorouracil+capecitabine+nivolumab,2024-01-17,2024-04-20,94,7,2,"5-fluorouracil, capecitabine, nivolumab","[{('regimen', ''): '5-fluorouracil+capecitabine+nivolumab', ('administratedate', 'min'): Timestamp('2024-03-25 00:00:00'), ('administratedate', 'max'): Timestamp('2024-04-20 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+nivolumab', ('administratedate', 'min'): Timestamp('2024-02-08 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-25 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2024-01-17 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-17 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
3,1,5-fluorouracil,5-fluorouracil,2023-01-01,2023-02-16,46,4,0,5-fluorouracil,"[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-16 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}]"
3,2,cetuximab,cetuximab+cisplatin,2023-04-06,2023-07-28,113,8,1,"cetuximab, cisplatin","[{('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-04-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-02 00:00:00'), ('regimen_status', 'first'): 'New Line (EGFR Addition/Switch)'}, {('regimen', ''): 'cetuximab+cisplatin', ('administratedate', 'min'): Timestamp('2023-05-02 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-28 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
4,1,capecitabine,5-fluorouracil+capecitabine+regorafenib,2023-01-01,2023-07-20,200,24,2,"5-fluorouracil, capecitabine, regorafenib","[{('regimen', ''): '5-fluorouracil+capecitabine+regorafenib', ('administratedate', 'min'): Timestamp('2023-04-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-20 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+regorafenib', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-25 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
4,2,encorafenib,capecitabine+encorafenib+regorafenib,2023-07-20,2023-08-19,30,5,2,"capecitabine, encorafenib, regorafenib","[{('regimen', ''): 'capecitabine+encorafenib', ('administratedate', 'min'): Timestamp('2023-08-03 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-03 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'capecitabine+encorafenib+regorafenib', ('administratedate', 'min'): Timestamp('2023-08-03 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-19 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-07-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-20 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
5,1,5-fluorouracil,5-fluorouracil+leucovorin+oxaliplatin+ramucirumab,2023-01-01,2023-03-30,88,28,3,"5-fluorouracil, leucovorin, oxaliplatin, ramucirumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-30 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
5,2,nivolumab,5-fluorouracil+leucovorin+nivolumab+oxaliplatin+ramucirumab,2023-03-30,2023-07-23,115,29,4,"5-fluorouracil, leucovorin, nivolumab, oxaliplatin, ramucirumab","[{('regimen', ''): '5-fluorouracil+leucovorin+nivolumab', ('administratedate', 'min'): Timestamp('2023-04-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-18 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+nivolumab+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-04-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-18 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+nivolumab+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-04-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-23 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+nivolumab', ('administratedate', 'min'): Timestamp('2023-04-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-18 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2023-03-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-30 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
5,3,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin+ramucirumab,2024-03-09,2024-11-14,250,35,4,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin, ramucirumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2024-03-09 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-09 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2024-04-26 00:00:00'), ('administratedate', 'max'): Timestamp('2024-11-14 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2024-03-09 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-09 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2024-03-09 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-09 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2024-03-09 00:00:00'), ('administratedate', 'max'): Timestamp('2024-04-26 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
5,4,bevacizumab,5-fluorouracil+bevacizumab+capecitabine,2024-11-14,2025-03-26,132,9,2,"5-fluorouracil, bevacizumab, capecitabine","[{('regimen', ''): '5-fluorouracil+bevacizumab+capecitabine', ('administratedate', 'min'): Timestamp('2025-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2025-03-26 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2024-11-14 00:00:00'), ('administratedate', 'max'): Timestamp('2024-11-14 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'bevacizumab+capecitabine', ('administratedate', 'min'): Timestamp('2024-11-25 00:00:00'), ('administratedate', 'max'): Timestamp('2024-12-18 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
6,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin,2023-01-01,2023-12-14,347,57,3,"5-fluorouracil, capecitabine, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-07-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-14 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-12 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
7,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin+nivolumab,2023-01-01,2023-04-24,113,25,4,"5-fluorouracil, capecitabine, irinotecan, leucovorin, nivolumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-03-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-03 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin+nivolumab', ('administratedate', 'min'): Timestamp('2023-04-03 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-24 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-21 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
7,2,pembrolizumab,pembrolizumab,2023-06-12,2024-02-15,248,14,0,pembrolizumab,"[{('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2023-06-12 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-15 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
7,3,encorafenib,encorafenib+pembrolizumab,2024-02-15,2024-04-10,55,5,1,"encorafenib, pembrolizumab","[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2024-02-15 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-15 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'encorafenib+pembrolizumab', ('administratedate', 'min'): Timestamp('2024-02-29 00:00:00'), ('administratedate', 'max'): Timestamp('2024-04-10 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
7,4,nivolumab,nivolumab,2024-05-13,2024-08-20,99,6,0,nivolumab,"[{('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2024-05-13 00:00:00'), ('administratedate', 'max'): Timestamp('2024-08-20 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
7,5,pembrolizumab,nivolumab+pembrolizumab,2024-08-20,2025-03-24,216,13,1,"nivolumab, pembrolizumab","[{('regimen', ''): 'nivolumab+pembrolizumab', ('administratedate', 'min'): Timestamp('2024-09-16 00:00:00'), ('administratedate', 'max'): Timestamp('2025-03-24 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2024-08-20 00:00:00'), ('administratedate', 'max'): Timestamp('2024-08-20 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
8,1,capecitabine,5-fluorouracil+capecitabine+oxaliplatin,2023-01-01,2023-07-13,193,26,2,"5-fluorouracil, capecitabine, oxaliplatin","[{('regimen', ''): '5-fluorouracil+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-07-03 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-13 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-03 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
8,2,panitumumab,panitumumab,2023-08-23,2023-10-17,55,4,0,panitumumab,"[{('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-08-23 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-17 00:00:00'), ('regimen_status', 'first'): 'New Line (EGFR Addition/Switch)'}]"
8,3,cetuximab,cetuximab+encorafenib+panitumumab,2023-10-17,2024-02-21,127,9,2,"cetuximab, encorafenib, panitumumab","[{('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-10-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-17 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'cetuximab+encorafenib+panitumumab', ('administratedate', 'min'): Timestamp('2023-11-02 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-21 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'cetuximab+panitumumab', ('administratedate', 'min'): Timestamp('2023-11-02 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-02 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
9,1,capecitabine,5-fluorouracil+capecitabine+encorafenib+oxaliplatin,2023-01-01,2023-04-28,117,17,3,"5-fluorouracil, capecitabine, encorafenib, oxaliplatin","[{('regimen', ''): '5-fluorouracil+capecitabine+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-04-11 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-28 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-03-05 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-11 00:00:00'), ('regimen_status', 'first'): 'Other Targeted Agent Addition (Within Window)'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-05 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
9,2,regorafenib,capecitabine+cetuximab+oxaliplatin+regorafenib,2023-04-28,2023-10-22,177,26,3,"capecitabine, cetuximab, oxaliplatin, regorafenib","[{('regimen', ''): 'capecitabine+cetuximab+oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2023-05-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-22 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2023-05-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-19 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+regorafenib', ('administratedate', 'min'): Timestamp('2023-05-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-19 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-04-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-28 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
10,1,5-fluorouracil,5-fluorouracil+cetuximab+irinotecan+leucovorin,2023-01-01,2023-04-19,108,32,3,"5-fluorouracil, cetuximab, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+cetuximab+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-19 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
10,2,regorafenib,5-fluorouracil+cetuximab+irinotecan+leucovorin+regorafenib,2023-04-19,2023-06-06,48,9,4,"5-fluorouracil, cetuximab, irinotecan, leucovorin, regorafenib","[{('regimen', ''): '5-fluorouracil+cetuximab+irinotecan+leucovorin+regorafenib', ('administratedate', 'min'): Timestamp('2023-05-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-06 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+regorafenib', ('administratedate', 'min'): Timestamp('2023-05-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-16 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin+regorafenib', ('administratedate', 'min'): Timestamp('2023-05-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-16 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+regorafenib', ('administratedate', 'min'): Timestamp('2023-05-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-16 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-04-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-19 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
10,3,ramucirumab,5-fluorouracil+capecitabine+cetuximab+irinotecan+leucovorin+ramucirumab,2023-06-06,2023-08-16,71,17,5,"5-fluorouracil, capecitabine, cetuximab, irinotecan, leucovorin, ramucirumab","[{('regimen', ''): '5-fluorouracil+capecitabine+cetuximab+irinotecan+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-07-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-16 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+cetuximab+irinotecan+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-15 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-28 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-28 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-28 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-06 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
11,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin,2023-01-01,2023-10-12,284,51,3,"5-fluorouracil, capecitabine, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-12 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-14 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
11,2,ramucirumab,ramucirumab,2023-11-11,2023-12-20,39,3,0,ramucirumab,"[{('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-11-11 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-20 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}]"
11,3,encorafenib,encorafenib+ramucirumab,2023-12-20,2024-02-13,55,4,1,"encorafenib, ramucirumab","[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-12-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-20 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'encorafenib+ramucirumab', ('administratedate', 'min'): Timestamp('2024-01-08 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-13 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
11,4,bevacizumab,5-fluorouracil+bevacizumab+ramucirumab,2024-02-13,2024-09-23,223,13,2,"5-fluorouracil, bevacizumab, ramucirumab","[{('regimen', ''): '5-fluorouracil+bevacizumab+ramucirumab', ('administratedate', 'min'): Timestamp('2024-05-27 00:00:00'), ('administratedate', 'max'): Timestamp('2024-09-23 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2024-02-13 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-13 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'bevacizumab+ramucirumab', ('administratedate', 'min'): Timestamp('2024-03-11 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-27 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
11,5,irinotecan,irinotecan,2024-11-02,2025-04-30,179,11,0,irinotecan,"[{('regimen', ''): 'irinotecan', ('administratedate', 'min'): Timestamp('2024-11-02 00:00:00'), ('administratedate', 'max'): Timestamp('2025-04-30 00:00:00'), ('regimen_status', 'first'): 'New Line (Topoisomerase Addition)'}]"
11,6,ramucirumab,irinotecan+ramucirumab,2025-04-30,2025-07-21,82,6,1,"irinotecan, ramucirumab","[{('regimen', ''): 'irinotecan+ramucirumab', ('administratedate', 'min'): Timestamp('2025-05-10 00:00:00'), ('administratedate', 'max'): Timestamp('2025-07-21 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2025-04-30 00:00:00'), ('administratedate', 'max'): Timestamp('2025-04-30 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}]"
11,7,panitumumab,irinotecan+panitumumab,2025-07-21,2025-10-09,80,5,1,"irinotecan, panitumumab","[{('regimen', ''): 'irinotecan+panitumumab', ('administratedate', 'min'): Timestamp('2025-08-03 00:00:00'), ('administratedate', 'max'): Timestamp('2025-10-09 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2025-07-21 00:00:00'), ('administratedate', 'max'): Timestamp('2025-07-21 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
11,8,bevacizumab,bevacizumab+leucovorin,2025-11-12,2026-01-24,73,6,1,"bevacizumab, leucovorin","[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2025-11-12 00:00:00'), ('administratedate', 'max'): Timestamp('2025-12-25 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'bevacizumab+leucovorin', ('administratedate', 'min'): Timestamp('2025-12-25 00:00:00'), ('administratedate', 'max'): Timestamp('2026-01-24 00:00:00'), ('regimen_status', 'first'): 'Continuation'}]"
12,1,capecitabine,5-fluorouracil+aflibercept+capecitabine+oxaliplatin,2023-01-01,2023-04-17,106,24,3,"5-fluorouracil, aflibercept, capecitabine, oxaliplatin","[{('regimen', ''): '5-fluorouracil+aflibercept+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-03-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-17 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'aflibercept+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-30 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
12,2,regorafenib,regorafenib,2023-06-02,2023-12-13,194,11,0,regorafenib,"[{('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-06-02 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-13 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
13,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin,2023-01-01,2023-05-12,131,27,3,"5-fluorouracil, capecitabine, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-05-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-12 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-12 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
13,2,oxaliplatin,5-fluorouracil+oxaliplatin,2023-05-12,2023-07-18,67,4,1,"5-fluorouracil, oxaliplatin","[{('regimen', ''): '5-fluorouracil+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-06-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-18 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-12 00:00:00'), ('regimen_status', 'first'): 'New Line (Platinum Addition)'}]"
14,1,capecitabine,capecitabine+cetuximab+oxaliplatin,2023-01-01,2023-04-15,104,27,2,"capecitabine, cetuximab, oxaliplatin","[{('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+cetuximab+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-15 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
14,2,pembrolizumab,capecitabine+cetuximab+oxaliplatin+pembrolizumab,2023-04-15,2023-06-03,49,10,3,"capecitabine, cetuximab, oxaliplatin, pembrolizumab","[{('regimen', ''): 'capecitabine+cetuximab+oxaliplatin+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-05-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-03 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+oxaliplatin+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-05-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-01 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-05-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2023-04-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-15 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
14,3,ramucirumab,capecitabine+cetuximab+oxaliplatin+ramucirumab,2023-06-03,2023-07-30,57,10,3,"capecitabine, cetuximab, oxaliplatin, ramucirumab","[{('regimen', ''): 'capecitabine+cetuximab+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-30 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-21 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-21 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-03 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-03 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
14,4,aflibercept,aflibercept,2025-03-12,2025-05-12,61,4,0,aflibercept,"[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2025-03-12 00:00:00'), ('administratedate', 'max'): Timestamp('2025-05-12 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}]"
14,5,panitumumab,aflibercept+panitumumab,2025-05-12,2025-11-14,186,11,1,"aflibercept, panitumumab","[{('regimen', ''): 'aflibercept+panitumumab', ('administratedate', 'min'): Timestamp('2025-06-03 00:00:00'), ('administratedate', 'max'): Timestamp('2025-11-14 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2025-05-12 00:00:00'), ('administratedate', 'max'): Timestamp('2025-05-12 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
15,1,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin,2023-01-01,2023-02-16,46,16,3,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-16 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-28 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
15,2,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin,2023-12-20,2024-01-13,24,6,3,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-12-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-20 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2024-01-13 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-13 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-12-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-20 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-12-20 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-13 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
16,1,5-fluorouracil,5-fluorouracil+capecitabine+ramucirumab,2023-01-01,2023-03-03,61,10,2,"5-fluorouracil, capecitabine, ramucirumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+ramucirumab', ('administratedate', 'min'): Timestamp('2023-01-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-03 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+ramucirumab', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-22 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
16,2,panitumumab,5-fluorouracil+panitumumab+ramucirumab,2023-03-03,2023-11-18,260,28,2,"5-fluorouracil, panitumumab, ramucirumab","[{('regimen', ''): '5-fluorouracil+panitumumab', ('administratedate', 'min'): Timestamp('2023-03-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-19 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+panitumumab+ramucirumab', ('administratedate', 'min'): Timestamp('2023-03-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-18 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-03-03 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-03 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
17,1,5-fluorouracil,5-fluorouracil+capecitabine+panitumumab,2023-01-01,2023-02-21,51,10,2,"5-fluorouracil, capecitabine, panitumumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+panitumumab', ('administratedate', 'min'): Timestamp('2023-02-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-21 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+panitumumab', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-21 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
17,2,aflibercept,5-fluorouracil+aflibercept+bevacizumab+panitumumab,2023-02-21,2023-05-23,91,12,3,"5-fluorouracil, aflibercept, bevacizumab, panitumumab","[{('regimen', ''): '5-fluorouracil+aflibercept', ('administratedate', 'min'): Timestamp('2023-03-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-14 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+aflibercept+bevacizumab+panitumumab', ('administratedate', 'min'): Timestamp('2023-03-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-23 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+aflibercept+panitumumab', ('administratedate', 'min'): Timestamp('2023-03-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-14 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-02-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-21 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
17,3,ramucirumab,5-fluorouracil+capecitabine+panitumumab+ramucirumab,2023-05-23,2023-07-28,66,9,3,"5-fluorouracil, capecitabine, panitumumab, ramucirumab","[{('regimen', ''): '5-fluorouracil+capecitabine+panitumumab+ramucirumab', ('administratedate', 'min'): Timestamp('2023-07-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-28 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+panitumumab+ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-04 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-15 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-04 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-04 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-05-23 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-23 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
17,4,5-fluorouracil,5-fluorouracil+capecitabine+panitumumab,2024-05-22,2024-06-27,36,6,2,"5-fluorouracil, capecitabine, panitumumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2024-05-22 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-22 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}, {('regimen', ''): '5-fluorouracil+capecitabine+panitumumab', ('administratedate', 'min'): Timestamp('2024-06-07 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-27 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+panitumumab', ('administratedate', 'min'): Timestamp('2024-05-22 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-07 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
17,5,ramucirumab,5-fluorouracil+panitumumab+ramucirumab,2024-06-27,2024-07-24,27,3,2,"5-fluorouracil, panitumumab, ramucirumab","[{('regimen', ''): '5-fluorouracil+panitumumab+ramucirumab', ('administratedate', 'min'): Timestamp('2024-07-24 00:00:00'), ('administratedate', 'max'): Timestamp('2024-07-24 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+ramucirumab', ('administratedate', 'min'): Timestamp('2024-07-24 00:00:00'), ('administratedate', 'max'): Timestamp('2024-07-24 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2024-06-27 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-27 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
18,1,5-fluorouracil,5-fluorouracil+capecitabine,2023-01-01,2023-07-13,193,12,1,"5-fluorouracil, capecitabine","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-23 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine', ('administratedate', 'min'): Timestamp('2023-07-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-13 00:00:00'), ('regimen_status', 'first'): 'Continuation'}]"
18,2,cisplatin,cisplatin+irinotecan,2023-08-18,2025-02-22,554,28,1,"cisplatin, irinotecan","[{('regimen', ''): 'cisplatin', ('administratedate', 'min'): Timestamp('2023-08-18 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-04 00:00:00'), ('regimen_status', 'first'): 'New Line (Platinum Addition)'}, {('regimen', ''): 'cisplatin+irinotecan', ('administratedate', 'min'): Timestamp('2024-06-23 00:00:00'), ('administratedate', 'max'): Timestamp('2025-02-22 00:00:00'), ('regimen_status', 'first'): 'Continuation'}]"
18,3,aflibercept,aflibercept,2025-04-08,2025-08-09,123,6,0,aflibercept,"[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2025-04-08 00:00:00'), ('administratedate', 'max'): Timestamp('2025-08-09 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}]"
19,1,5-fluorouracil,5-fluorouracil,2023-01-01,2023-04-08,97,6,0,5-fluorouracil,"[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-08 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}]"
19,2,ramucirumab,5-fluorouracil+ramucirumab,2023-04-08,2023-06-01,54,4,1,"5-fluorouracil, ramucirumab","[{('regimen', ''): '5-fluorouracil+ramucirumab', ('administratedate', 'min'): Timestamp('2023-04-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-04-08 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-08 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}]"
19,3,regorafenib,5-fluorouracil+regorafenib,2023-06-01,2023-09-22,113,7,1,"5-fluorouracil, regorafenib","[{('regimen', ''): '5-fluorouracil+regorafenib', ('administratedate', 'min'): Timestamp('2023-06-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-22 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-06-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-01 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
19,4,cetuximab,cetuximab,2023-11-06,2023-11-28,22,2,0,cetuximab,"[{('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-11-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-28 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
19,5,bevacizumab,bevacizumab,2024-01-06,2024-02-06,31,3,0,bevacizumab,"[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2024-01-06 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-06 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
19,6,aflibercept,aflibercept+bevacizumab,2024-02-06,2024-04-14,68,5,1,"aflibercept, bevacizumab","[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2024-02-06 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-06 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'aflibercept+bevacizumab', ('administratedate', 'min'): Timestamp('2024-02-19 00:00:00'), ('administratedate', 'max'): Timestamp('2024-04-14 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
19,7,cetuximab,bevacizumab+cetuximab,2024-04-14,2024-06-28,75,5,1,"bevacizumab, cetuximab","[{('regimen', ''): 'bevacizumab+cetuximab', ('administratedate', 'min'): Timestamp('2024-04-27 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-28 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2024-04-14 00:00:00'), ('administratedate', 'max'): Timestamp('2024-04-14 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
20,1,5-fluorouracil,5-fluorouracil+cetuximab+leucovorin+oxaliplatin,2023-01-01,2023-02-22,52,24,3,"5-fluorouracil, cetuximab, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+cetuximab+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-22 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
20,2,encorafenib,encorafenib,2023-02-22,2023-02-22,0,1,0,encorafenib,"[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-02-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-22 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
20,3,regorafenib,regorafenib,2023-04-04,2023-05-18,44,4,0,regorafenib,"[{('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-04-04 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-18 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
20,4,bevacizumab,bevacizumab+regorafenib,2023-05-18,2023-11-28,194,13,1,"bevacizumab, regorafenib","[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2023-05-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-18 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'bevacizumab+regorafenib', ('administratedate', 'min'): Timestamp('2023-06-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-28 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
21,1,capecitabine,5-fluorouracil+capecitabine+oxaliplatin,2023-01-01,2023-06-17,167,20,2,"5-fluorouracil, capecitabine, oxaliplatin","[{('regimen', ''): '5-fluorouracil+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-03-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-17 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-13 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
21,2,ramucirumab,5-fluorouracil+capecitabine+oxaliplatin+ramucirumab,2023-06-17,2023-10-16,121,15,3,"5-fluorouracil, capecitabine, oxaliplatin, ramucirumab","[{('regimen', ''): '5-fluorouracil+capecitabine+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-08-02 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-16 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-07-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-02 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+ramucirumab', ('administratedate', 'min'): Timestamp('2023-07-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-07 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-17 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}]"
21,3,nivolumab,nivolumab,2023-10-16,2023-10-16,0,1,0,nivolumab,"[{('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2023-10-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-16 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
22,1,capecitabine,capecitabine+oxaliplatin,2023-01-01,2023-04-11,100,16,1,"capecitabine, oxaliplatin","[{('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-11 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
22,2,aflibercept,aflibercept+leucovorin,2023-05-19,2023-07-04,46,4,1,"aflibercept, leucovorin","[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-05-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-19 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}, {('regimen', ''): 'aflibercept+leucovorin', ('administratedate', 'min'): Timestamp('2023-05-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-04 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
22,3,regorafenib,aflibercept+regorafenib,2023-07-04,2023-09-21,79,6,1,"aflibercept, regorafenib","[{('regimen', ''): 'aflibercept+regorafenib', ('administratedate', 'min'): Timestamp('2023-07-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-21 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-07-04 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-04 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
22,4,panitumumab,capecitabine+panitumumab,2023-10-20,2024-06-17,241,16,1,"capecitabine, panitumumab","[{('regimen', ''): 'capecitabine+panitumumab', ('administratedate', 'min'): Timestamp('2024-02-01 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-17 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-10-20 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-01 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
23,1,capecitabine,5-fluorouracil+bevacizumab+capecitabine,2023-01-01,2023-06-14,164,12,2,"5-fluorouracil, bevacizumab, capecitabine","[{('regimen', ''): '5-fluorouracil+bevacizumab+capecitabine', ('administratedate', 'min'): Timestamp('2023-02-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-14 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'bevacizumab+capecitabine', ('administratedate', 'min'): Timestamp('2023-01-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-13 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-28 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}]"
23,2,panitumumab,capecitabine+panitumumab,2023-06-14,2023-10-30,138,9,1,"capecitabine, panitumumab","[{('regimen', ''): 'capecitabine+panitumumab', ('administratedate', 'min'): Timestamp('2023-07-04 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-30 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-06-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-14 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
23,3,nivolumab,capecitabine+nivolumab,2023-10-30,2023-12-05,36,3,1,"capecitabine, nivolumab","[{('regimen', ''): 'capecitabine+nivolumab', ('administratedate', 'min'): Timestamp('2023-11-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-05 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2023-10-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-30 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
24,1,5-fluorouracil,5-fluorouracil+bevacizumab+capecitabine+leucovorin+oxaliplatin,2023-01-01,2023-04-29,118,40,4,"5-fluorouracil, bevacizumab, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+bevacizumab+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-03-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-29 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+bevacizumab+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-06 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
24,2,cetuximab,capecitabine+cetuximab,2023-06-08,2024-02-29,266,16,1,"capecitabine, cetuximab","[{('regimen', ''): 'capecitabine+cetuximab', ('administratedate', 'min'): Timestamp('2023-07-27 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-29 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-06-08 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-27 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
24,3,cisplatin,cisplatin,2024-04-20,2024-09-17,150,9,0,cisplatin,"[{('regimen', ''): 'cisplatin', ('administratedate', 'min'): Timestamp('2024-04-20 00:00:00'), ('administratedate', 'max'): Timestamp('2024-09-17 00:00:00'), ('regimen_status', 'first'): 'New Line (Platinum Addition)'}]"
25,1,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin+regorafenib,2023-01-01,2023-09-04,246,60,4,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin, regorafenib","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2023-06-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-04 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-20 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
25,2,ramucirumab,5-fluorouracil+leucovorin+oxaliplatin+ramucirumab+regorafenib,2023-09-04,2023-11-27,84,21,4,"5-fluorouracil, leucovorin, oxaliplatin, ramucirumab, regorafenib","[{('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-09-23 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-23 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+ramucirumab+regorafenib', ('administratedate', 'min'): Timestamp('2023-09-23 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-27 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-09-23 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-23 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+ramucirumab', ('administratedate', 'min'): Timestamp('2023-09-23 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-23 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-09-04 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-04 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
25,3,panitumumab,panitumumab,2023-11-27,2023-11-27,0,1,0,panitumumab,"[{('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-11-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-27 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
25,4,encorafenib,cetuximab+encorafenib+irinotecan+panitumumab,2024-01-05,2024-06-16,163,13,3,"cetuximab, encorafenib, irinotecan, panitumumab","[{('regimen', ''): 'cetuximab+encorafenib', ('administratedate', 'min'): Timestamp('2024-01-05 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-15 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'cetuximab+encorafenib+irinotecan+panitumumab', ('administratedate', 'min'): Timestamp('2024-06-16 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-16 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'cetuximab+encorafenib+panitumumab', ('administratedate', 'min'): Timestamp('2024-01-15 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-20 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2024-01-05 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-05 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
25,5,nivolumab,irinotecan+nivolumab,2024-06-16,2024-09-11,87,5,1,"irinotecan, nivolumab","[{('regimen', ''): 'irinotecan+nivolumab', ('administratedate', 'min'): Timestamp('2024-07-11 00:00:00'), ('administratedate', 'max'): Timestamp('2024-09-11 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2024-06-16 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-16 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
25,6,encorafenib,encorafenib+irinotecan,2024-09-11,2024-10-13,32,3,1,"encorafenib, irinotecan","[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2024-09-11 00:00:00'), ('administratedate', 'max'): Timestamp('2024-09-11 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'encorafenib+irinotecan', ('administratedate', 'min'): Timestamp('2024-09-22 00:00:00'), ('administratedate', 'max'): Timestamp('2024-10-13 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
25,7,panitumumab,irinotecan+panitumumab,2024-10-13,2025-03-04,142,9,1,"irinotecan, panitumumab","[{('regimen', ''): 'irinotecan+panitumumab', ('administratedate', 'min'): Timestamp('2024-11-04 00:00:00'), ('administratedate', 'max'): Timestamp('2025-03-04 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2024-10-13 00:00:00'), ('administratedate', 'max'): Timestamp('2024-10-13 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
26,1,5-fluorouracil,5-fluorouracil+capecitabine+encorafenib+irinotecan+leucovorin,2023-01-01,2023-10-07,279,72,4,"5-fluorouracil, capecitabine, encorafenib, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+encorafenib+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-06-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-07 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+encorafenib+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-07 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
26,2,cetuximab,5-fluorouracil+cetuximab+encorafenib+irinotecan+leucovorin,2023-10-07,2023-12-15,69,21,4,"5-fluorouracil, cetuximab, encorafenib, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil+cetuximab', ('administratedate', 'min'): Timestamp('2023-10-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-18 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+cetuximab+encorafenib+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-10-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-15 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+cetuximab+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-10-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-18 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+cetuximab+leucovorin', ('administratedate', 'min'): Timestamp('2023-10-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-18 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-10-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-07 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
26,3,pembrolizumab,pembrolizumab,2024-01-23,2024-08-22,212,13,0,pembrolizumab,"[{('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2024-01-23 00:00:00'), ('administratedate', 'max'): Timestamp('2024-08-22 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
27,1,5-fluorouracil,5-fluorouracil+capecitabine+cetuximab+irinotecan+leucovorin,2023-01-01,2023-08-15,226,18,4,"5-fluorouracil, capecitabine, cetuximab, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+cetuximab+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-03-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-15 00:00:00'), ('regimen_status', 'first'): 'EGFR Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-31 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-31 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
27,2,pembrolizumab,cetuximab+pembrolizumab,2023-08-15,2023-10-01,47,3,1,"cetuximab, pembrolizumab","[{('regimen', ''): 'cetuximab+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-09-05 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2023-08-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-15 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
28,1,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin,2023-01-01,2023-05-29,148,27,3,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-08 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-29 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-08 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
28,2,ramucirumab,5-fluorouracil+capecitabine+leucovorin+oxaliplatin+ramucirumab,2023-05-29,2023-10-07,131,22,4,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin, ramucirumab","[{('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-08-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-07 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-31 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): 'leucovorin+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-10 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-06-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-10 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-05-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-29 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}]"
28,3,pembrolizumab,pembrolizumab,2023-11-20,2023-12-10,20,2,0,pembrolizumab,"[{('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2023-11-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-10 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
28,4,ramucirumab,ramucirumab,2024-01-13,2024-07-22,191,12,0,ramucirumab,"[{('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2024-01-13 00:00:00'), ('administratedate', 'max'): Timestamp('2024-07-22 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
29,1,5-fluorouracil,5-fluorouracil+irinotecan+leucovorin+nivolumab,2023-01-01,2023-06-09,159,19,3,"5-fluorouracil, irinotecan, leucovorin, nivolumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-04 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+nivolumab', ('administratedate', 'min'): Timestamp('2023-04-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-09 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
30,1,capecitabine,5-fluorouracil+capecitabine+oxaliplatin,2023-01-01,2023-06-12,162,20,2,"5-fluorouracil, capecitabine, oxaliplatin","[{('regimen', ''): '5-fluorouracil+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-04-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-12 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-17 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
30,2,regorafenib,5-fluorouracil+capecitabine+oxaliplatin+regorafenib,2023-06-12,2023-12-30,201,17,3,"5-fluorouracil, capecitabine, oxaliplatin, regorafenib","[{('regimen', ''): '5-fluorouracil+capecitabine+oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2023-12-08 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-30 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine+oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2023-07-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-17 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+regorafenib', ('administratedate', 'min'): Timestamp('2023-07-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-07 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-06-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-12 00:00:00'), ('regimen_status', 'first'): 'New Line (Other Targeted Agent)'}]"
30,3,aflibercept,5-fluorouracil+aflibercept+capecitabine+pembrolizumab,2023-12-30,2024-03-18,79,8,3,"5-fluorouracil, aflibercept, capecitabine, pembrolizumab","[{('regimen', ''): '5-fluorouracil+aflibercept', ('administratedate', 'min'): Timestamp('2024-01-12 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-12 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+aflibercept+capecitabine+pembrolizumab', ('administratedate', 'min'): Timestamp('2024-01-28 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-18 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+aflibercept+pembrolizumab', ('administratedate', 'min'): Timestamp('2024-01-12 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-12 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-12-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-30 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
30,4,encorafenib,encorafenib,2024-03-18,2024-03-18,0,1,0,encorafenib,"[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2024-03-18 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-18 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
30,5,5-fluorouracil,5-fluorouracil+oxaliplatin,2025-01-26,2025-07-09,164,10,1,"5-fluorouracil, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2025-01-26 00:00:00'), ('administratedate', 'max'): Timestamp('2025-01-26 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}, {('regimen', ''): '5-fluorouracil+oxaliplatin', ('administratedate', 'min'): Timestamp('2025-03-01 00:00:00'), ('administratedate', 'max'): Timestamp('2025-07-09 00:00:00'), ('regimen_status', 'first'): 'Continuation'}]"
30,6,panitumumab,oxaliplatin+panitumumab,2025-07-09,2026-01-30,205,14,1,"oxaliplatin, panitumumab","[{('regimen', ''): 'oxaliplatin+panitumumab', ('administratedate', 'min'): Timestamp('2025-07-27 00:00:00'), ('administratedate', 'max'): Timestamp('2026-01-30 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2025-07-09 00:00:00'), ('administratedate', 'max'): Timestamp('2025-07-09 00:00:00'), ('regimen_status', 'first'): 'New Line (EGFR Addition/Switch)'}]"
31,1,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin,2023-01-01,2023-07-31,211,42,3,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-03-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-31 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-17 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
31,2,cetuximab,5-fluorouracil+capecitabine+cetuximab+leucovorin+oxaliplatin,2023-07-31,2023-12-05,127,22,4,"5-fluorouracil, capecitabine, cetuximab, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil+capecitabine+cetuximab+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-09-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-05 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine+cetuximab+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-08-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-25 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-07-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-31 00:00:00'), ('regimen_status', 'first'): 'New Line (EGFR Addition/Switch)'}, {('regimen', ''): 'cetuximab+leucovorin', ('administratedate', 'min'): Timestamp('2023-08-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-25 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'cetuximab+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-08-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-25 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
31,3,aflibercept,aflibercept,2023-12-05,2023-12-05,0,1,0,aflibercept,"[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-12-05 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-05 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
31,4,nivolumab,5-fluorouracil+capecitabine+nivolumab,2024-01-20,2024-10-24,278,14,2,"5-fluorouracil, capecitabine, nivolumab","[{('regimen', ''): '5-fluorouracil+capecitabine+nivolumab', ('administratedate', 'min'): Timestamp('2024-06-18 00:00:00'), ('administratedate', 'max'): Timestamp('2024-10-24 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine+nivolumab', ('administratedate', 'min'): Timestamp('2024-01-20 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-05 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2024-01-20 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-20 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
32,1,5-fluorouracil,5-fluorouracil+encorafenib+irinotecan+leucovorin,2023-01-01,2023-02-26,56,20,3,"5-fluorouracil, encorafenib, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+encorafenib+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-26 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
32,2,ramucirumab,5-fluorouracil+capecitabine+encorafenib+irinotecan+leucovorin+ramucirumab,2023-02-26,2023-05-15,78,17,5,"5-fluorouracil, capecitabine, encorafenib, irinotecan, leucovorin, ramucirumab","[{('regimen', ''): '5-fluorouracil+capecitabine+encorafenib+irinotecan+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-04-04 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-15 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+encorafenib+irinotecan+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-03-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-04 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-03-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-22 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-03-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-22 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+ramucirumab', ('administratedate', 'min'): Timestamp('2023-03-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-22 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-02-26 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-26 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
32,3,panitumumab,5-fluorouracil+encorafenib+irinotecan+leucovorin+panitumumab,2023-05-15,2023-06-16,32,9,4,"5-fluorouracil, encorafenib, irinotecan, leucovorin, panitumumab","[{('regimen', ''): '5-fluorouracil+encorafenib+irinotecan+leucovorin+panitumumab', ('administratedate', 'min'): Timestamp('2023-05-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-16 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): 'encorafenib+irinotecan+leucovorin+panitumumab', ('administratedate', 'min'): Timestamp('2023-05-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-29 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'irinotecan+leucovorin+panitumumab', ('administratedate', 'min'): Timestamp('2023-05-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-29 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'leucovorin+panitumumab', ('administratedate', 'min'): Timestamp('2023-05-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-29 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-05-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-15 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
32,4,pembrolizumab,5-fluorouracil+encorafenib+irinotecan+leucovorin+pembrolizumab,2023-06-16,2023-07-01,15,5,4,"5-fluorouracil, encorafenib, irinotecan, leucovorin, pembrolizumab","[{('regimen', ''): '5-fluorouracil+encorafenib+irinotecan+leucovorin+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-07-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-07-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-07-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-07-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2023-06-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-16 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
32,5,bevacizumab,bevacizumab,2023-07-27,2023-12-27,153,9,0,bevacizumab,"[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2023-07-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-27 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
32,6,panitumumab,bevacizumab+panitumumab,2023-12-27,2024-04-26,121,7,1,"bevacizumab, panitumumab","[{('regimen', ''): 'bevacizumab+panitumumab', ('administratedate', 'min'): Timestamp('2024-01-22 00:00:00'), ('administratedate', 'max'): Timestamp('2024-04-26 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-12-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-27 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
32,7,pembrolizumab,bevacizumab+pembrolizumab,2024-04-26,2024-06-09,44,4,1,"bevacizumab, pembrolizumab","[{('regimen', ''): 'bevacizumab+pembrolizumab', ('administratedate', 'min'): Timestamp('2024-05-11 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-09 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2024-04-26 00:00:00'), ('administratedate', 'max'): Timestamp('2024-04-26 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
32,8,bevacizumab,bevacizumab,2025-01-28,2025-03-12,43,3,0,bevacizumab,"[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2025-01-28 00:00:00'), ('administratedate', 'max'): Timestamp('2025-03-12 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}]"
32,9,encorafenib,encorafenib+leucovorin,2025-04-17,2025-09-26,162,12,1,"encorafenib, leucovorin","[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2025-04-17 00:00:00'), ('administratedate', 'max'): Timestamp('2025-07-02 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'encorafenib+leucovorin', ('administratedate', 'min'): Timestamp('2025-07-02 00:00:00'), ('administratedate', 'max'): Timestamp('2025-09-26 00:00:00'), ('regimen_status', 'first'): 'Continuation'}]"
33,1,5-fluorouracil,5-fluorouracil+bevacizumab+irinotecan+leucovorin,2023-01-01,2023-03-29,87,19,3,"5-fluorouracil, bevacizumab, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+bevacizumab+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-02-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-29 00:00:00'), ('regimen_status', 'first'): 'Anti-VEGF Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-07 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
33,2,aflibercept,5-fluorouracil+aflibercept+irinotecan+leucovorin,2023-03-29,2023-09-23,178,31,3,"5-fluorouracil, aflibercept, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil+aflibercept', ('administratedate', 'min'): Timestamp('2023-04-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-12 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+aflibercept+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-04-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-23 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+aflibercept+leucovorin', ('administratedate', 'min'): Timestamp('2023-04-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-12 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-03-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-29 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
33,3,panitumumab,5-fluorouracil+irinotecan+leucovorin+panitumumab,2023-09-23,2023-10-13,20,4,3,"5-fluorouracil, irinotecan, leucovorin, panitumumab","[{('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+panitumumab', ('administratedate', 'min'): Timestamp('2023-10-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-13 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): 'irinotecan+leucovorin+panitumumab', ('administratedate', 'min'): Timestamp('2023-10-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-13 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'leucovorin+panitumumab', ('administratedate', 'min'): Timestamp('2023-10-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-13 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-09-23 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-23 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
33,4,bevacizumab,bevacizumab,2023-11-16,2024-04-24,160,10,0,bevacizumab,"[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2023-11-16 00:00:00'), ('administratedate', 'max'): Timestamp('2024-04-24 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
33,5,regorafenib,bevacizumab+regorafenib,2024-04-24,2024-05-29,35,4,1,"bevacizumab, regorafenib","[{('regimen', ''): 'bevacizumab+regorafenib', ('administratedate', 'min'): Timestamp('2024-05-05 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-29 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2024-04-24 00:00:00'), ('administratedate', 'max'): Timestamp('2024-04-24 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
33,6,bevacizumab,bevacizumab+irinotecan,2025-01-09,2025-11-29,324,17,1,"bevacizumab, irinotecan","[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2025-01-09 00:00:00'), ('administratedate', 'max'): Timestamp('2025-04-22 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}, {('regimen', ''): 'bevacizumab+irinotecan', ('administratedate', 'min'): Timestamp('2025-06-01 00:00:00'), ('administratedate', 'max'): Timestamp('2025-11-29 00:00:00'), ('regimen_status', 'first'): 'Continuation'}]"
34,1,5-fluorouracil,5-fluorouracil+irinotecan+leucovorin,2023-01-01,2023-03-31,89,18,2,"5-fluorouracil, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-31 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
35,1,5-fluorouracil,5-fluorouracil+aflibercept+capecitabine+leucovorin+oxaliplatin,2023-01-01,2023-10-28,300,72,4,"5-fluorouracil, aflibercept, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+aflibercept+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-02-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-28 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+aflibercept+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-17 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
35,2,regorafenib,regorafenib,2023-12-11,2024-06-26,198,13,0,regorafenib,"[{('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-12-11 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-26 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
35,3,bevacizumab,bevacizumab+regorafenib,2024-06-26,2024-09-07,73,5,1,"bevacizumab, regorafenib","[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2024-06-26 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-26 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'bevacizumab+regorafenib', ('administratedate', 'min'): Timestamp('2024-07-07 00:00:00'), ('administratedate', 'max'): Timestamp('2024-09-07 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
36,1,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin+ramucirumab,2023-01-01,2023-11-20,323,88,4,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin, ramucirumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-03-24 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-20 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-24 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
36,2,cisplatin,cisplatin,2024-10-15,2024-11-30,46,4,0,cisplatin,"[{('regimen', ''): 'cisplatin', ('administratedate', 'min'): Timestamp('2024-10-15 00:00:00'), ('administratedate', 'max'): Timestamp('2024-11-30 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}]"
37,1,5-fluorouracil,5-fluorouracil+leucovorin+oxaliplatin+panitumumab,2023-01-01,2023-05-19,138,40,3,"5-fluorouracil, leucovorin, oxaliplatin, panitumumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-19 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
37,2,cetuximab,5-fluorouracil+capecitabine+cetuximab+leucovorin+oxaliplatin+panitumumab,2023-05-19,2023-07-20,62,17,5,"5-fluorouracil, capecitabine, cetuximab, leucovorin, oxaliplatin, panitumumab","[{('regimen', ''): '5-fluorouracil+capecitabine+cetuximab+leucovorin+oxaliplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-06-23 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-20 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+cetuximab', ('administratedate', 'min'): Timestamp('2023-05-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-29 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+cetuximab+leucovorin', ('administratedate', 'min'): Timestamp('2023-05-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-29 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+cetuximab+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-29 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+cetuximab+leucovorin+oxaliplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-05-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-23 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-05-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-19 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
37,3,ramucirumab,5-fluorouracil+leucovorin+oxaliplatin+panitumumab+ramucirumab,2023-07-20,2023-09-16,58,13,4,"5-fluorouracil, leucovorin, oxaliplatin, panitumumab, ramucirumab","[{('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+panitumumab+ramucirumab', ('administratedate', 'min'): Timestamp('2023-07-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-16 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): 'leucovorin+oxaliplatin+panitumumab+ramucirumab', ('administratedate', 'min'): Timestamp('2023-07-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-31 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'leucovorin+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-07-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-31 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-07-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-31 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-07-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-20 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
38,1,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+nivolumab+oxaliplatin,2023-01-01,2023-10-10,282,58,4,"5-fluorouracil, capecitabine, leucovorin, nivolumab, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+nivolumab+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-04-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-10 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+nivolumab+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-28 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-31 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
39,1,capecitabine,5-fluorouracil+capecitabine,2023-01-01,2023-10-04,276,15,1,"5-fluorouracil, capecitabine","[{('regimen', ''): '5-fluorouracil+capecitabine', ('administratedate', 'min'): Timestamp('2023-01-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-04 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}]"
39,2,cetuximab,cetuximab,2023-11-25,2024-09-03,283,16,0,cetuximab,"[{('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-11-25 00:00:00'), ('administratedate', 'max'): Timestamp('2024-09-03 00:00:00'), ('regimen_status', 'first'): 'New Line (EGFR Addition/Switch)'}]"
39,3,panitumumab,irinotecan+panitumumab,2024-10-03,2025-04-18,197,13,1,"irinotecan, panitumumab","[{('regimen', ''): 'irinotecan+panitumumab', ('administratedate', 'min'): Timestamp('2024-10-03 00:00:00'), ('administratedate', 'max'): Timestamp('2025-04-18 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2024-10-03 00:00:00'), ('administratedate', 'max'): Timestamp('2024-10-03 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
39,4,encorafenib,encorafenib+panitumumab,2025-04-18,2025-05-02,14,2,1,"encorafenib, panitumumab","[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2025-04-18 00:00:00'), ('administratedate', 'max'): Timestamp('2025-04-18 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'encorafenib+panitumumab', ('administratedate', 'min'): Timestamp('2025-05-02 00:00:00'), ('administratedate', 'max'): Timestamp('2025-05-02 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
40,1,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin+panitumumab,2023-01-01,2023-02-26,56,20,4,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin, panitumumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-02-26 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-26 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-26 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
40,2,pembrolizumab,5-fluorouracil+capecitabine+leucovorin+oxaliplatin+panitumumab+pembrolizumab,2023-02-26,2023-06-06,100,14,5,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin, panitumumab, pembrolizumab","[{('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin+panitumumab+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-06-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-06 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+panitumumab+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-03-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-04 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-03-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-22 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-03-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-22 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-03-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-22 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2023-02-26 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-26 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
40,3,encorafenib,capecitabine+encorafenib,2023-06-06,2023-10-14,130,8,1,"capecitabine, encorafenib","[{('regimen', ''): 'capecitabine+encorafenib', ('administratedate', 'min'): Timestamp('2023-06-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-14 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-06-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-06 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
40,4,irinotecan,capecitabine+cetuximab+irinotecan,2023-10-14,2023-11-11,28,4,2,"capecitabine, cetuximab, irinotecan","[{('regimen', ''): 'capecitabine+cetuximab+irinotecan', ('administratedate', 'min'): Timestamp('2023-11-11 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-11 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'capecitabine+irinotecan', ('administratedate', 'min'): Timestamp('2023-10-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-11 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'irinotecan', ('administratedate', 'min'): Timestamp('2023-10-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-14 00:00:00'), ('regimen_status', 'first'): 'New Line (Topoisomerase Addition)'}]"
41,1,capecitabine,bevacizumab+capecitabine,2023-01-01,2023-02-09,39,8,1,"bevacizumab, capecitabine","[{('regimen', ''): 'bevacizumab+capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-09 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}]"
41,2,cisplatin,cisplatin,2024-01-22,2024-06-15,145,8,0,cisplatin,"[{('regimen', ''): 'cisplatin', ('administratedate', 'min'): Timestamp('2024-01-22 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-15 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}]"
42,1,5-fluorouracil,5-fluorouracil+irinotecan+leucovorin,2023-01-01,2023-07-13,193,39,2,"5-fluorouracil, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-13 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
42,2,aflibercept,5-fluorouracil+aflibercept+capecitabine+irinotecan+leucovorin,2023-07-13,2023-11-11,121,22,4,"5-fluorouracil, aflibercept, capecitabine, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil+aflibercept', ('administratedate', 'min'): Timestamp('2023-07-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-25 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+aflibercept+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-09-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-11 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+aflibercept+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-07-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-12 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+aflibercept+leucovorin', ('administratedate', 'min'): Timestamp('2023-07-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-25 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-07-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-13 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}]"
42,3,regorafenib,regorafenib,2023-12-15,2023-12-26,11,2,0,regorafenib,"[{('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-12-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-26 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
42,4,encorafenib,encorafenib,2024-11-15,2025-02-13,90,7,0,encorafenib,"[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2024-11-15 00:00:00'), ('administratedate', 'max'): Timestamp('2025-02-13 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}]"
42,5,bevacizumab,bevacizumab+encorafenib,2025-02-13,2025-06-25,132,8,1,"bevacizumab, encorafenib","[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2025-02-13 00:00:00'), ('administratedate', 'max'): Timestamp('2025-02-13 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'bevacizumab+encorafenib', ('administratedate', 'min'): Timestamp('2025-02-27 00:00:00'), ('administratedate', 'max'): Timestamp('2025-06-25 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
42,6,aflibercept,aflibercept+encorafenib,2025-06-25,2025-10-01,98,6,1,"aflibercept, encorafenib","[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2025-06-25 00:00:00'), ('administratedate', 'max'): Timestamp('2025-06-25 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'aflibercept+encorafenib', ('administratedate', 'min'): Timestamp('2025-07-08 00:00:00'), ('administratedate', 'max'): Timestamp('2025-10-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
43,1,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin,2023-01-01,2023-08-02,213,42,3,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-02 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-30 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
43,2,cetuximab,cetuximab,2023-08-02,2023-08-02,0,1,0,cetuximab,"[{('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-08-02 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-02 00:00:00'), ('regimen_status', 'first'): 'New Line (EGFR Addition/Switch)'}]"
44,1,5-fluorouracil,5-fluorouracil,2023-01-01,2023-12-13,346,21,0,5-fluorouracil,"[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-13 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}]"
44,2,encorafenib,encorafenib,2024-01-22,2024-03-03,41,4,0,encorafenib,"[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2024-01-22 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-03 00:00:00'), ('regimen_status', 'first'): 'New Line (Other Targeted Agent)'}]"
44,3,pembrolizumab,pembrolizumab,2024-04-12,2024-04-28,16,2,0,pembrolizumab,"[{('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2024-04-12 00:00:00'), ('administratedate', 'max'): Timestamp('2024-04-28 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
44,4,regorafenib,regorafenib,2024-06-12,2024-10-30,140,9,0,regorafenib,"[{('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2024-06-12 00:00:00'), ('administratedate', 'max'): Timestamp('2024-10-30 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
44,5,panitumumab,panitumumab,2024-10-30,2024-10-30,0,1,0,panitumumab,"[{('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2024-10-30 00:00:00'), ('administratedate', 'max'): Timestamp('2024-10-30 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
45,1,5-fluorouracil,5-fluorouracil+bevacizumab+leucovorin+oxaliplatin,2023-01-01,2023-06-08,158,44,3,"5-fluorouracil, bevacizumab, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+bevacizumab+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-08 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
46,1,5-fluorouracil,5-fluorouracil+pembrolizumab+regorafenib,2023-01-01,2023-03-14,72,13,2,"5-fluorouracil, pembrolizumab, regorafenib","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+pembrolizumab+regorafenib', ('administratedate', 'min'): Timestamp('2023-01-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-14 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+regorafenib', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-19 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
46,2,bevacizumab,5-fluorouracil+bevacizumab+capecitabine+regorafenib,2023-03-14,2023-10-12,212,23,3,"5-fluorouracil, bevacizumab, capecitabine, regorafenib","[{('regimen', ''): '5-fluorouracil+bevacizumab', ('administratedate', 'min'): Timestamp('2023-04-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-06 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+bevacizumab+capecitabine+regorafenib', ('administratedate', 'min'): Timestamp('2023-05-23 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-12 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+bevacizumab+regorafenib', ('administratedate', 'min'): Timestamp('2023-04-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-23 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2023-03-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-14 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
46,3,ramucirumab,ramucirumab,2023-11-14,2024-01-30,77,5,0,ramucirumab,"[{('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-11-14 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-30 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
47,1,5-fluorouracil,5-fluorouracil+capecitabine+cetuximab+irinotecan+leucovorin,2023-01-01,2023-05-07,126,25,4,"5-fluorouracil, capecitabine, cetuximab, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+cetuximab+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-02-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-07 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+cetuximab+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-27 00:00:00'), ('regimen_status', 'first'): 'EGFR Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-31 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
47,2,cisplatin,5-fluorouracil+capecitabine+cisplatin+irinotecan+leucovorin,2023-05-07,2024-06-17,407,42,4,"5-fluorouracil, capecitabine, cisplatin, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil+capecitabine+cisplatin+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-06-04 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-17 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): 'capecitabine+cisplatin+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-05-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-18 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'cisplatin', ('administratedate', 'min'): Timestamp('2023-05-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-07 00:00:00'), ('regimen_status', 'first'): 'New Line (Platinum Addition)'}, {('regimen', ''): 'cisplatin+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-05-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-18 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'cisplatin+leucovorin', ('administratedate', 'min'): Timestamp('2023-05-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-18 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
47,3,aflibercept,aflibercept+cisplatin,2024-06-17,2024-07-08,21,2,1,"aflibercept, cisplatin","[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2024-06-17 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-17 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}, {('regimen', ''): 'aflibercept+cisplatin', ('administratedate', 'min'): Timestamp('2024-07-08 00:00:00'), ('administratedate', 'max'): Timestamp('2024-07-08 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
47,4,regorafenib,oxaliplatin+regorafenib,2024-08-25,2025-04-04,222,11,1,"oxaliplatin, regorafenib","[{('regimen', ''): 'oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2025-03-19 00:00:00'), ('administratedate', 'max'): Timestamp('2025-04-04 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2024-08-25 00:00:00'), ('administratedate', 'max'): Timestamp('2025-02-11 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
47,5,encorafenib,encorafenib+oxaliplatin,2025-04-04,2025-10-27,206,12,1,"encorafenib, oxaliplatin","[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2025-04-04 00:00:00'), ('administratedate', 'max'): Timestamp('2025-04-04 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2025-04-20 00:00:00'), ('administratedate', 'max'): Timestamp('2025-10-27 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
48,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin+pembrolizumab,2023-01-01,2023-11-10,313,59,4,"5-fluorouracil, capecitabine, irinotecan, leucovorin, pembrolizumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-02-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-27 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-09-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-10 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
48,2,oxaliplatin,encorafenib+oxaliplatin,2023-12-20,2024-03-27,98,8,1,"encorafenib, oxaliplatin","[{('regimen', ''): 'encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2024-01-25 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-27 00:00:00'), ('regimen_status', 'first'): 'Other Targeted Agent Addition (Within Window)'}, {('regimen', ''): 'oxaliplatin', ('administratedate', 'min'): Timestamp('2023-12-20 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-25 00:00:00'), ('regimen_status', 'first'): 'New Line (Platinum Addition)'}]"
48,3,regorafenib,oxaliplatin+regorafenib,2024-03-27,2024-09-07,164,10,1,"oxaliplatin, regorafenib","[{('regimen', ''): 'oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2024-04-12 00:00:00'), ('administratedate', 'max'): Timestamp('2024-09-07 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2024-03-27 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-27 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
48,4,pembrolizumab,pembrolizumab,2025-06-08,2025-07-26,48,4,0,pembrolizumab,"[{('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2025-06-08 00:00:00'), ('administratedate', 'max'): Timestamp('2025-07-26 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}]"
48,5,bevacizumab,bevacizumab+pembrolizumab,2025-07-26,2025-12-18,145,10,1,"bevacizumab, pembrolizumab","[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2025-07-26 00:00:00'), ('administratedate', 'max'): Timestamp('2025-07-26 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'bevacizumab+pembrolizumab', ('administratedate', 'min'): Timestamp('2025-08-11 00:00:00'), ('administratedate', 'max'): Timestamp('2025-12-18 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
49,1,capecitabine,5-fluorouracil+capecitabine+regorafenib,2023-01-01,2023-07-31,211,16,2,"5-fluorouracil, capecitabine, regorafenib","[{('regimen', ''): '5-fluorouracil+capecitabine+regorafenib', ('administratedate', 'min'): Timestamp('2023-01-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-31 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+regorafenib', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-25 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
50,1,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin+regorafenib,2023-01-01,2024-03-14,438,56,4,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin, regorafenib","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2023-04-24 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-14 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-13 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2023-02-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-24 00:00:00'), ('regimen_status', 'first'): 'Other Targeted Agent Addition (Within Window)'}]"
50,2,encorafenib,encorafenib+regorafenib,2024-03-14,2024-08-11,150,11,1,"encorafenib, regorafenib","[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2024-03-14 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-14 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'encorafenib+regorafenib', ('administratedate', 'min'): Timestamp('2024-04-09 00:00:00'), ('administratedate', 'max'): Timestamp('2024-08-11 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
50,3,pembrolizumab,pembrolizumab,2024-09-20,2024-12-29,100,7,0,pembrolizumab,"[{('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2024-09-20 00:00:00'), ('administratedate', 'max'): Timestamp('2024-12-29 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
50,4,encorafenib,encorafenib+pembrolizumab,2024-12-29,2025-06-07,160,9,1,"encorafenib, pembrolizumab","[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2024-12-29 00:00:00'), ('administratedate', 'max'): Timestamp('2024-12-29 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'encorafenib+pembrolizumab', ('administratedate', 'min'): Timestamp('2025-01-19 00:00:00'), ('administratedate', 'max'): Timestamp('2025-06-07 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
51,1,5-fluorouracil,5-fluorouracil+panitumumab,2023-01-01,2023-03-15,73,12,1,"5-fluorouracil, panitumumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+panitumumab', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-15 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
51,2,regorafenib,5-fluorouracil+panitumumab+regorafenib,2023-03-15,2023-04-21,37,5,2,"5-fluorouracil, panitumumab, regorafenib","[{('regimen', ''): '5-fluorouracil+panitumumab+regorafenib', ('administratedate', 'min'): Timestamp('2023-03-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-21 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+regorafenib', ('administratedate', 'min'): Timestamp('2023-03-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-28 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-03-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-15 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
51,3,cetuximab,5-fluorouracil+cetuximab+panitumumab,2023-04-21,2023-06-26,66,9,2,"5-fluorouracil, cetuximab, panitumumab","[{('regimen', ''): '5-fluorouracil+cetuximab', ('administratedate', 'min'): Timestamp('2023-05-08 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-08 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+cetuximab+panitumumab', ('administratedate', 'min'): Timestamp('2023-05-08 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-26 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-04-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-21 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
51,4,regorafenib,5-fluorouracil+panitumumab+regorafenib,2023-06-26,2024-05-24,333,23,2,"5-fluorouracil, panitumumab, regorafenib","[{('regimen', ''): '5-fluorouracil+panitumumab+regorafenib', ('administratedate', 'min'): Timestamp('2023-07-06 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-24 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab+regorafenib', ('administratedate', 'min'): Timestamp('2023-07-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-06 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-06-26 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-26 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
51,5,cisplatin,cisplatin+regorafenib,2024-05-24,2024-06-15,22,2,1,"cisplatin, regorafenib","[{('regimen', ''): 'cisplatin', ('administratedate', 'min'): Timestamp('2024-05-24 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-24 00:00:00'), ('regimen_status', 'first'): 'New Line (Platinum Addition)'}, {('regimen', ''): 'cisplatin+regorafenib', ('administratedate', 'min'): Timestamp('2024-06-15 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-15 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
52,1,5-fluorouracil,5-fluorouracil+capecitabine+encorafenib+irinotecan+leucovorin,2023-01-01,2023-04-03,92,22,4,"5-fluorouracil, capecitabine, encorafenib, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+encorafenib+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-03-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-03 00:00:00'), ('regimen_status', 'first'): 'Other Targeted Agent Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-03-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-13 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-13 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
52,2,pembrolizumab,pembrolizumab,2023-05-25,2023-06-29,35,3,0,pembrolizumab,"[{('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2023-05-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-29 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
52,3,panitumumab,encorafenib+panitumumab+pembrolizumab,2023-06-29,2023-07-26,27,4,2,"encorafenib, panitumumab, pembrolizumab","[{('regimen', ''): 'encorafenib+panitumumab+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-07-26 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-26 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-06-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-29 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'panitumumab+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-07-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-26 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
53,1,capecitabine,capecitabine+oxaliplatin,2023-01-01,2023-10-24,296,38,1,"capecitabine, oxaliplatin","[{('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-24 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
54,1,capecitabine,5-fluorouracil+capecitabine+encorafenib,2023-01-01,2023-07-16,196,13,2,"5-fluorouracil, capecitabine, encorafenib","[{('regimen', ''): '5-fluorouracil+capecitabine', ('administratedate', 'min'): Timestamp('2023-02-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-16 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+capecitabine+encorafenib', ('administratedate', 'min'): Timestamp('2023-02-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-16 00:00:00'), ('regimen_status', 'first'): 'Other Targeted Agent Addition (Within Window)'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-06 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}]"
54,2,capecitabine,aflibercept+capecitabine+panitumumab,2024-03-04,2024-09-02,182,13,2,"aflibercept, capecitabine, panitumumab","[{('regimen', ''): 'aflibercept+capecitabine', ('administratedate', 'min'): Timestamp('2024-03-04 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-31 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'aflibercept+capecitabine+panitumumab', ('administratedate', 'min'): Timestamp('2024-03-31 00:00:00'), ('administratedate', 'max'): Timestamp('2024-09-02 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2024-03-04 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-04 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}]"
54,3,nivolumab,capecitabine+nivolumab,2024-09-02,2024-11-03,62,5,1,"capecitabine, nivolumab","[{('regimen', ''): 'capecitabine+nivolumab', ('administratedate', 'min'): Timestamp('2024-09-28 00:00:00'), ('administratedate', 'max'): Timestamp('2024-11-03 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2024-09-02 00:00:00'), ('administratedate', 'max'): Timestamp('2024-09-02 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
54,4,regorafenib,regorafenib,2024-12-13,2025-04-08,116,8,0,regorafenib,"[{('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2024-12-13 00:00:00'), ('administratedate', 'max'): Timestamp('2025-04-08 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
55,1,capecitabine,5-fluorouracil+capecitabine,2023-01-01,2023-10-13,285,18,1,"5-fluorouracil, capecitabine","[{('regimen', ''): '5-fluorouracil+capecitabine', ('administratedate', 'min'): Timestamp('2023-05-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-13 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-26 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}]"
55,2,panitumumab,irinotecan+panitumumab,2023-10-13,2024-05-24,224,11,1,"irinotecan, panitumumab","[{('regimen', ''): 'irinotecan+panitumumab', ('administratedate', 'min'): Timestamp('2023-12-05 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-24 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-10-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-13 00:00:00'), ('regimen_status', 'first'): 'New Line (EGFR Addition/Switch)'}]"
56,1,5-fluorouracil,5-fluorouracil+aflibercept+capecitabine+leucovorin+oxaliplatin,2023-01-01,2023-11-05,308,58,4,"5-fluorouracil, aflibercept, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+aflibercept+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-06-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-05 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+aflibercept+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-16 00:00:00'), ('regimen_status', 'first'): 'Anti-VEGF Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-30 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
57,1,5-fluorouracil,5-fluorouracil+capecitabine+panitumumab,2023-01-01,2023-05-15,134,20,2,"5-fluorouracil, capecitabine, panitumumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+panitumumab', ('administratedate', 'min'): Timestamp('2023-05-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-15 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+panitumumab', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-15 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
57,2,aflibercept,5-fluorouracil+aflibercept+panitumumab,2023-05-15,2023-08-09,86,11,2,"5-fluorouracil, aflibercept, panitumumab","[{('regimen', ''): '5-fluorouracil+aflibercept', ('administratedate', 'min'): Timestamp('2023-05-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-27 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+aflibercept+panitumumab', ('administratedate', 'min'): Timestamp('2023-05-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-09 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-05-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-15 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
57,3,cisplatin,5-fluorouracil+cisplatin+panitumumab,2023-08-09,2023-09-30,52,5,2,"5-fluorouracil, cisplatin, panitumumab","[{('regimen', ''): '5-fluorouracil+cisplatin', ('administratedate', 'min'): Timestamp('2023-09-04 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-04 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+cisplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-09-04 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-30 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'cisplatin', ('administratedate', 'min'): Timestamp('2023-08-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-09 00:00:00'), ('regimen_status', 'first'): 'New Line (Platinum Addition)'}]"
57,4,pembrolizumab,pembrolizumab,2023-09-30,2023-09-30,0,1,0,pembrolizumab,"[{('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2023-09-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-30 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
57,5,cetuximab,cetuximab+regorafenib,2023-11-13,2024-07-14,244,15,1,"cetuximab, regorafenib","[{('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-11-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-24 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'cetuximab+regorafenib', ('administratedate', 'min'): Timestamp('2023-11-24 00:00:00'), ('administratedate', 'max'): Timestamp('2024-07-14 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
58,1,5-fluorouracil,5-fluorouracil+irinotecan+leucovorin,2023-01-01,2023-04-02,91,21,2,"5-fluorouracil, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-02 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
58,2,panitumumab,panitumumab,2023-04-02,2023-04-02,0,1,0,panitumumab,"[{('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-04-02 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-02 00:00:00'), ('regimen_status', 'first'): 'New Line (EGFR Addition/Switch)'}]"
58,3,nivolumab,nivolumab+pembrolizumab,2023-05-17,2023-07-18,62,6,1,"nivolumab, pembrolizumab","[{('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2023-05-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-17 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'nivolumab+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-05-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-18 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
58,4,regorafenib,nivolumab+regorafenib,2023-07-18,2024-01-29,195,14,1,"nivolumab, regorafenib","[{('regimen', ''): 'nivolumab+regorafenib', ('administratedate', 'min'): Timestamp('2023-08-12 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-29 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-07-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-18 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
59,1,capecitabine,5-fluorouracil+capecitabine+oxaliplatin+pembrolizumab,2023-01-01,2023-07-14,194,26,3,"5-fluorouracil, capecitabine, oxaliplatin, pembrolizumab","[{('regimen', ''): '5-fluorouracil+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-06 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): '5-fluorouracil+capecitabine+oxaliplatin+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-05-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-14 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-12 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
59,2,panitumumab,capecitabine+oxaliplatin+panitumumab,2023-07-14,2023-09-10,58,7,2,"capecitabine, oxaliplatin, panitumumab","[{('regimen', ''): 'capecitabine+oxaliplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-08-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-10 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+panitumumab', ('administratedate', 'min'): Timestamp('2023-08-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-06 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-07-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-14 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
59,3,regorafenib,regorafenib,2023-09-10,2023-09-10,0,1,0,regorafenib,"[{('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-09-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-10 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
60,1,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin,2023-01-01,2023-05-07,126,27,3,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-07 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-09 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
60,2,encorafenib,encorafenib,2023-06-29,2023-08-26,58,4,0,encorafenib,"[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-06-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-26 00:00:00'), ('regimen_status', 'first'): 'New Line (Other Targeted Agent)'}]"
61,1,capecitabine,capecitabine+pembrolizumab,2023-01-01,2023-05-12,131,9,1,"capecitabine, pembrolizumab","[{('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-13 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-02-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-12 00:00:00'), ('regimen_status', 'first'): 'Continuation'}]"
61,2,nivolumab,5-fluorouracil+capecitabine+nivolumab,2023-05-12,2023-08-15,95,7,2,"5-fluorouracil, capecitabine, nivolumab","[{('regimen', ''): '5-fluorouracil+capecitabine+nivolumab', ('administratedate', 'min'): Timestamp('2023-06-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-15 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+nivolumab', ('administratedate', 'min'): Timestamp('2023-05-24 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-24 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2023-05-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-12 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
61,3,ramucirumab,capecitabine+ramucirumab,2023-08-15,2023-10-11,57,4,1,"capecitabine, ramucirumab","[{('regimen', ''): 'capecitabine+ramucirumab', ('administratedate', 'min'): Timestamp('2023-08-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-11 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-08-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-15 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
61,4,aflibercept,aflibercept+irinotecan,2023-11-15,2024-06-02,200,12,1,"aflibercept, irinotecan","[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-11-15 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-13 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'aflibercept+irinotecan', ('administratedate', 'min'): Timestamp('2024-02-13 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-02 00:00:00'), ('regimen_status', 'first'): 'Continuation'}]"
61,5,regorafenib,aflibercept+regorafenib,2024-06-02,2024-07-28,56,5,1,"aflibercept, regorafenib","[{('regimen', ''): 'aflibercept+regorafenib', ('administratedate', 'min'): Timestamp('2024-06-13 00:00:00'), ('administratedate', 'max'): Timestamp('2024-07-28 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2024-06-02 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-02 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
62,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin,2023-01-01,2023-07-15,195,45,3,"5-fluorouracil, capecitabine, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-04-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-15 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-18 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
62,2,aflibercept,5-fluorouracil+aflibercept+capecitabine+cetuximab+irinotecan+leucovorin,2023-07-15,2023-11-05,113,23,5,"5-fluorouracil, aflibercept, capecitabine, cetuximab, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil+aflibercept', ('administratedate', 'min'): Timestamp('2023-08-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-10 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+aflibercept+capecitabine+cetuximab+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-08-23 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-05 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+aflibercept+cetuximab+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-08-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-23 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+aflibercept+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-08-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-10 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+aflibercept+leucovorin', ('administratedate', 'min'): Timestamp('2023-08-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-10 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-07-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-15 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}]"
63,1,5-fluorouracil,5-fluorouracil,2023-01-01,2023-06-18,168,9,0,5-fluorouracil,"[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-18 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}]"
63,2,encorafenib,encorafenib,2023-07-31,2023-11-07,99,6,0,encorafenib,"[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-07-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-07 00:00:00'), ('regimen_status', 'first'): 'New Line (Other Targeted Agent)'}]"
64,1,5-fluorouracil,5-fluorouracil+irinotecan+leucovorin+regorafenib,2023-01-01,2023-04-09,98,22,3,"5-fluorouracil, irinotecan, leucovorin, regorafenib","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-02 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+regorafenib', ('administratedate', 'min'): Timestamp('2023-02-02 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-09 00:00:00'), ('regimen_status', 'first'): 'Other Targeted Agent Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
65,1,capecitabine,capecitabine+oxaliplatin,2023-01-01,2023-06-11,161,18,1,"capecitabine, oxaliplatin","[{('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-11 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
65,2,bevacizumab,bevacizumab+ramucirumab,2023-07-27,2023-10-27,92,8,1,"bevacizumab, ramucirumab","[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2023-07-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-27 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}, {('regimen', ''): 'bevacizumab+ramucirumab', ('administratedate', 'min'): Timestamp('2023-07-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-27 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
66,1,5-fluorouracil,5-fluorouracil+irinotecan+leucovorin+panitumumab,2023-01-01,2023-06-11,161,17,3,"5-fluorouracil, irinotecan, leucovorin, panitumumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-30 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+panitumumab', ('administratedate', 'min'): Timestamp('2023-03-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-11 00:00:00'), ('regimen_status', 'first'): 'EGFR Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
66,2,bevacizumab,bevacizumab+panitumumab,2023-06-11,2023-10-20,131,8,1,"bevacizumab, panitumumab","[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2023-06-11 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-11 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'bevacizumab+panitumumab', ('administratedate', 'min'): Timestamp('2023-07-03 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-20 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
67,1,5-fluorouracil,5-fluorouracil,2023-01-01,2023-01-24,23,3,0,5-fluorouracil,"[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-24 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}]"
68,1,5-fluorouracil,5-fluorouracil+bevacizumab+capecitabine+leucovorin+oxaliplatin,2023-01-01,2024-04-03,458,43,4,"5-fluorouracil, bevacizumab, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+bevacizumab+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-08 00:00:00'), ('administratedate', 'max'): Timestamp('2024-04-03 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+bevacizumab+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-04 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
69,1,5-fluorouracil,5-fluorouracil+capecitabine+panitumumab,2023-01-01,2023-04-18,107,9,2,"5-fluorouracil, capecitabine, panitumumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine', ('administratedate', 'min'): Timestamp('2023-01-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+capecitabine+panitumumab', ('administratedate', 'min'): Timestamp('2023-03-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-18 00:00:00'), ('regimen_status', 'first'): 'EGFR Addition (Within Window)'}]"
69,2,pembrolizumab,5-fluorouracil+pembrolizumab,2023-04-18,2023-09-07,142,10,1,"5-fluorouracil, pembrolizumab","[{('regimen', ''): '5-fluorouracil+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-04-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-07 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2023-04-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-18 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
69,3,regorafenib,5-fluorouracil+regorafenib,2023-09-07,2023-11-11,65,4,1,"5-fluorouracil, regorafenib","[{('regimen', ''): '5-fluorouracil+regorafenib', ('administratedate', 'min'): Timestamp('2023-09-24 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-11 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-09-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-07 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
70,1,capecitabine,capecitabine,2023-01-01,2023-07-29,209,12,0,capecitabine,"[{('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-29 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}]"
70,2,bevacizumab,bevacizumab+encorafenib,2023-08-25,2024-02-10,169,11,1,"bevacizumab, encorafenib","[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2023-08-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-21 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}, {('regimen', ''): 'bevacizumab+encorafenib', ('administratedate', 'min'): Timestamp('2023-09-21 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-10 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
71,1,5-fluorouracil,5-fluorouracil+capecitabine+encorafenib+leucovorin+oxaliplatin,2023-01-01,2023-07-14,194,39,4,"5-fluorouracil, capecitabine, encorafenib, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+encorafenib+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-03-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-14 00:00:00'), ('regimen_status', 'first'): 'Other Targeted Agent Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-17 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-19 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
71,2,aflibercept,aflibercept,2023-08-23,2024-01-16,146,9,0,aflibercept,"[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-08-23 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-16 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
71,3,ramucirumab,encorafenib+ramucirumab,2024-10-15,2025-07-27,285,16,1,"encorafenib, ramucirumab","[{('regimen', ''): 'encorafenib+ramucirumab', ('administratedate', 'min'): Timestamp('2024-10-27 00:00:00'), ('administratedate', 'max'): Timestamp('2025-07-27 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2024-10-15 00:00:00'), ('administratedate', 'max'): Timestamp('2024-10-27 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}]"
72,1,capecitabine,5-fluorouracil+capecitabine+oxaliplatin+panitumumab,2023-01-01,2023-04-17,106,15,3,"5-fluorouracil, capecitabine, oxaliplatin, panitumumab","[{('regimen', ''): '5-fluorouracil+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-02-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-22 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+capecitabine+oxaliplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-02-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-17 00:00:00'), ('regimen_status', 'first'): 'EGFR Addition (Within Window)'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-01 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
72,2,cisplatin,5-fluorouracil+capecitabine+cisplatin+leucovorin+oxaliplatin,2023-04-17,2023-10-08,174,22,4,"5-fluorouracil, capecitabine, cisplatin, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil+capecitabine+cisplatin+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-09-05 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-08 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine+cisplatin', ('administratedate', 'min'): Timestamp('2023-05-05 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-05 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'capecitabine+cisplatin+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-24 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-05 00:00:00'), ('regimen_status', 'first'): 'Chemo Addition (Within Window)'}, {('regimen', ''): 'capecitabine+cisplatin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-05 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-24 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'cisplatin', ('administratedate', 'min'): Timestamp('2023-04-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-17 00:00:00'), ('regimen_status', 'first'): 'New Line (Platinum Addition)'}]"
73,1,5-fluorouracil,5-fluorouracil+irinotecan+leucovorin+nivolumab,2023-01-01,2023-03-07,65,16,3,"5-fluorouracil, irinotecan, leucovorin, nivolumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-21 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+nivolumab', ('administratedate', 'min'): Timestamp('2023-01-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-07 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
73,2,bevacizumab,5-fluorouracil+bevacizumab+irinotecan+leucovorin,2023-03-07,2023-07-11,126,22,3,"5-fluorouracil, bevacizumab, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil+bevacizumab', ('administratedate', 'min'): Timestamp('2023-03-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-31 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+bevacizumab+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-03-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-11 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+bevacizumab+leucovorin', ('administratedate', 'min'): Timestamp('2023-03-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-31 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2023-03-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-07 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
73,3,pembrolizumab,pembrolizumab,2023-08-19,2024-02-21,186,11,0,pembrolizumab,"[{('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2023-08-19 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-21 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
73,4,encorafenib,encorafenib+pembrolizumab,2024-02-21,2024-03-17,25,2,1,"encorafenib, pembrolizumab","[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2024-02-21 00:00:00'), ('administratedate', 'max'): Timestamp('2024-02-21 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'encorafenib+pembrolizumab', ('administratedate', 'min'): Timestamp('2024-03-17 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-17 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
73,5,cetuximab,capecitabine+cetuximab,2024-04-10,2024-12-03,237,13,1,"capecitabine, cetuximab","[{('regimen', ''): 'capecitabine+cetuximab', ('administratedate', 'min'): Timestamp('2024-09-21 00:00:00'), ('administratedate', 'max'): Timestamp('2024-12-03 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2024-04-10 00:00:00'), ('administratedate', 'max'): Timestamp('2024-08-21 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
74,1,capecitabine,5-fluorouracil+capecitabine+oxaliplatin,2023-01-01,2023-05-09,128,14,2,"5-fluorouracil, capecitabine, oxaliplatin","[{('regimen', ''): '5-fluorouracil+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-09 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-09 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
74,2,aflibercept,5-fluorouracil+aflibercept+capecitabine+oxaliplatin,2023-05-09,2023-08-29,112,15,3,"5-fluorouracil, aflibercept, capecitabine, oxaliplatin","[{('regimen', ''): '5-fluorouracil+aflibercept+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-06-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-29 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+aflibercept+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-24 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-24 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-05-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-09 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}, {('regimen', ''): 'aflibercept+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-24 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-24 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
74,3,pembrolizumab,bevacizumab+capecitabine+oxaliplatin+pembrolizumab,2023-08-29,2023-10-07,39,6,3,"bevacizumab, capecitabine, oxaliplatin, pembrolizumab","[{('regimen', ''): 'bevacizumab+capecitabine+oxaliplatin+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-09-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-07 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+oxaliplatin+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-09-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-21 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-09-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-21 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2023-08-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-29 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
75,1,5-fluorouracil,5-fluorouracil+irinotecan+leucovorin+pembrolizumab,2023-01-01,2023-02-09,39,16,3,"5-fluorouracil, irinotecan, leucovorin, pembrolizumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-25 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-01-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-09 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
75,2,ramucirumab,5-fluorouracil+irinotecan+leucovorin+ramucirumab,2023-02-09,2023-08-08,180,28,3,"5-fluorouracil, irinotecan, leucovorin, ramucirumab","[{('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-02-24 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-08 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-02-24 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-24 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+ramucirumab', ('administratedate', 'min'): Timestamp('2023-02-24 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-24 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-02-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-09 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
75,3,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin,2024-03-10,2024-06-20,102,18,3,"5-fluorouracil, capecitabine, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2024-03-10 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-10 00:00:00'), ('regimen_status', 'first'): 'New Line (Gap)'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2024-06-20 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-20 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2024-03-10 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-20 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2024-03-10 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-10 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
75,4,ramucirumab,cisplatin+ramucirumab,2024-06-20,2024-08-28,69,4,1,"cisplatin, ramucirumab","[{('regimen', ''): 'cisplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2024-07-28 00:00:00'), ('administratedate', 'max'): Timestamp('2024-08-28 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2024-06-20 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-20 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}]"
75,5,encorafenib,cisplatin+encorafenib,2024-08-28,2025-02-09,165,8,1,"cisplatin, encorafenib","[{('regimen', ''): 'cisplatin+encorafenib', ('administratedate', 'min'): Timestamp('2024-09-17 00:00:00'), ('administratedate', 'max'): Timestamp('2025-02-09 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2024-08-28 00:00:00'), ('administratedate', 'max'): Timestamp('2024-08-28 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
75,6,panitumumab,encorafenib+panitumumab,2025-03-13,2026-02-17,341,20,1,"encorafenib, panitumumab","[{('regimen', ''): 'encorafenib+panitumumab', ('administratedate', 'min'): Timestamp('2025-04-06 00:00:00'), ('administratedate', 'max'): Timestamp('2026-02-17 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2025-03-13 00:00:00'), ('administratedate', 'max'): Timestamp('2025-04-06 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
76,1,5-fluorouracil,5-fluorouracil+aflibercept+leucovorin+oxaliplatin,2023-01-01,2023-04-28,117,28,3,"5-fluorouracil, aflibercept, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+aflibercept+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-03-02 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-28 00:00:00'), ('regimen_status', 'first'): 'Anti-VEGF Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-02 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
76,2,bevacizumab,5-fluorouracil+bevacizumab,2023-06-02,2023-08-18,77,8,1,"5-fluorouracil, bevacizumab","[{('regimen', ''): '5-fluorouracil+bevacizumab', ('administratedate', 'min'): Timestamp('2023-07-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-18 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2023-06-02 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-09 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
76,3,aflibercept,aflibercept+bevacizumab,2023-08-18,2024-01-26,161,9,1,"aflibercept, bevacizumab","[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-08-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-18 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'aflibercept+bevacizumab', ('administratedate', 'min'): Timestamp('2023-09-12 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-26 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
77,1,5-fluorouracil,5-fluorouracil+bevacizumab+capecitabine,2023-01-01,2023-11-03,306,18,2,"5-fluorouracil, bevacizumab, capecitabine","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-17 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+bevacizumab', ('administratedate', 'min'): Timestamp('2023-03-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-13 00:00:00'), ('regimen_status', 'first'): 'Anti-VEGF Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+bevacizumab+capecitabine', ('administratedate', 'min'): Timestamp('2023-04-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-03 00:00:00'), ('regimen_status', 'first'): 'Continuation'}]"
77,2,regorafenib,bevacizumab+regorafenib,2023-12-03,2024-05-20,169,10,1,"bevacizumab, regorafenib","[{('regimen', ''): 'bevacizumab+regorafenib', ('administratedate', 'min'): Timestamp('2023-12-03 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-20 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-12-03 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-03 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
78,1,5-fluorouracil,5-fluorouracil+capecitabine,2023-01-01,2023-03-27,85,7,1,"5-fluorouracil, capecitabine","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-19 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine', ('administratedate', 'min'): Timestamp('2023-02-02 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-27 00:00:00'), ('regimen_status', 'first'): 'Continuation'}]"
79,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin,2023-01-01,2023-05-18,137,30,3,"5-fluorouracil, capecitabine, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-04-11 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-18 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-11 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
80,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin+panitumumab,2023-01-01,2023-07-01,181,40,4,"5-fluorouracil, capecitabine, irinotecan, leucovorin, panitumumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin+panitumumab', ('administratedate', 'min'): Timestamp('2023-06-15 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-01 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-19 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+panitumumab', ('administratedate', 'min'): Timestamp('2023-03-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-15 00:00:00'), ('regimen_status', 'first'): 'EGFR Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
80,2,oxaliplatin,5-fluorouracil+capecitabine+irinotecan+leucovorin+nivolumab+oxaliplatin,2023-07-01,2024-09-30,457,33,5,"5-fluorouracil, capecitabine, irinotecan, leucovorin, nivolumab, oxaliplatin","[{('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin+nivolumab+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-08-21 00:00:00'), ('administratedate', 'max'): Timestamp('2024-09-30 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-08-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-21 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-07-26 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-21 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-07-26 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-26 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-07-26 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-26 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'oxaliplatin', ('administratedate', 'min'): Timestamp('2023-07-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-01 00:00:00'), ('regimen_status', 'first'): 'New Line (Platinum Addition)'}]"
80,3,pembrolizumab,nivolumab+pembrolizumab,2024-09-30,2024-11-12,43,3,1,"nivolumab, pembrolizumab","[{('regimen', ''): 'nivolumab+pembrolizumab', ('administratedate', 'min'): Timestamp('2024-10-21 00:00:00'), ('administratedate', 'max'): Timestamp('2024-11-12 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2024-09-30 00:00:00'), ('administratedate', 'max'): Timestamp('2024-09-30 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
81,1,capecitabine,5-fluorouracil+bevacizumab+capecitabine+oxaliplatin,2023-01-01,2023-07-31,211,42,3,"5-fluorouracil, bevacizumab, capecitabine, oxaliplatin","[{('regimen', ''): '5-fluorouracil+bevacizumab+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-02-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-31 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'bevacizumab+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-16 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
82,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin+nivolumab,2023-01-01,2023-09-14,256,49,4,"5-fluorouracil, capecitabine, irinotecan, leucovorin, nivolumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-02-26 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-12 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin+nivolumab', ('administratedate', 'min'): Timestamp('2023-07-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-14 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-26 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
83,1,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin,2023-01-01,2023-06-09,159,33,3,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-02-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-09 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-14 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
83,2,encorafenib,encorafenib+oxaliplatin,2023-07-18,2024-06-12,330,16,1,"encorafenib, oxaliplatin","[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-07-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-15 00:00:00'), ('regimen_status', 'first'): 'New Line (Other Targeted Agent)'}, {('regimen', ''): 'encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-11-03 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-12 00:00:00'), ('regimen_status', 'first'): 'Continuation'}]"
84,1,capecitabine,capecitabine+oxaliplatin+panitumumab,2023-01-01,2023-05-05,124,21,2,"capecitabine, oxaliplatin, panitumumab","[{('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-11 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+oxaliplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-02-11 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-05 00:00:00'), ('regimen_status', 'first'): 'EGFR Addition (Within Window)'}]"
84,2,nivolumab,capecitabine+nivolumab+oxaliplatin,2023-05-05,2023-06-28,54,7,2,"capecitabine, nivolumab, oxaliplatin","[{('regimen', ''): 'capecitabine+nivolumab', ('administratedate', 'min'): Timestamp('2023-05-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-30 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'capecitabine+nivolumab+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-28 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2023-05-05 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-05 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
84,3,bevacizumab,bevacizumab+cisplatin,2023-08-17,2023-10-30,74,6,1,"bevacizumab, cisplatin","[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2023-08-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-23 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'bevacizumab+cisplatin', ('administratedate', 'min'): Timestamp('2023-09-23 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-30 00:00:00'), ('regimen_status', 'first'): 'Continuation'}]"
84,4,panitumumab,panitumumab,2023-10-30,2023-10-30,0,1,0,panitumumab,"[{('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-10-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-30 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
84,5,encorafenib,encorafenib,2023-12-07,2024-03-23,107,6,0,encorafenib,"[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-12-07 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-23 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
84,6,nivolumab,encorafenib+nivolumab,2024-03-23,2024-09-21,182,12,1,"encorafenib, nivolumab","[{('regimen', ''): 'encorafenib+nivolumab', ('administratedate', 'min'): Timestamp('2024-04-09 00:00:00'), ('administratedate', 'max'): Timestamp('2024-09-21 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2024-03-23 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-23 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
85,1,5-fluorouracil,5-fluorouracil+panitumumab,2023-01-01,2023-02-17,47,8,1,"5-fluorouracil, panitumumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+panitumumab', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-17 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
85,2,encorafenib,5-fluorouracil+encorafenib+panitumumab,2023-02-17,2023-03-31,42,5,2,"5-fluorouracil, encorafenib, panitumumab","[{('regimen', ''): '5-fluorouracil+encorafenib', ('administratedate', 'min'): Timestamp('2023-03-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-07 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+encorafenib+panitumumab', ('administratedate', 'min'): Timestamp('2023-03-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-31 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-02-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-17 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
85,3,regorafenib,regorafenib,2023-03-31,2023-03-31,0,1,0,regorafenib,"[{('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-03-31 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-31 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
85,4,bevacizumab,bevacizumab,2023-05-16,2023-07-07,52,4,0,bevacizumab,"[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2023-05-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-07 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
85,5,aflibercept,aflibercept+bevacizumab+panitumumab,2023-07-07,2023-07-30,23,3,2,"aflibercept, bevacizumab, panitumumab","[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-07-07 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-07 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'aflibercept+bevacizumab', ('administratedate', 'min'): Timestamp('2023-07-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-30 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'aflibercept+bevacizumab+panitumumab', ('administratedate', 'min'): Timestamp('2023-07-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-30 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
86,1,5-fluorouracil,5-fluorouracil+leucovorin+oxaliplatin,2023-01-01,2023-05-16,135,24,2,"5-fluorouracil, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-16 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
86,2,encorafenib,encorafenib,2023-06-30,2023-07-23,23,2,0,encorafenib,"[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-06-30 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-23 00:00:00'), ('regimen_status', 'first'): 'New Line (Other Targeted Agent)'}]"
87,1,capecitabine,capecitabine+oxaliplatin+panitumumab,2023-01-01,2023-06-03,153,23,2,"capecitabine, oxaliplatin, panitumumab","[{('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-01 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+oxaliplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-04-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-03 00:00:00'), ('regimen_status', 'first'): 'EGFR Addition (Within Window)'}]"
87,2,encorafenib,5-fluorouracil+capecitabine+encorafenib+oxaliplatin,2023-06-03,2023-11-14,164,21,3,"5-fluorouracil, capecitabine, encorafenib, oxaliplatin","[{('regimen', ''): '5-fluorouracil+capecitabine+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-08-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-14 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine+encorafenib', ('administratedate', 'min'): Timestamp('2023-06-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-20 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'capecitabine+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-06-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-17 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-06-03 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-03 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
87,3,panitumumab,cisplatin+panitumumab,2023-11-14,2024-10-13,334,19,1,"cisplatin, panitumumab","[{('regimen', ''): 'cisplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-12-20 00:00:00'), ('administratedate', 'max'): Timestamp('2024-10-13 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-11-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-14 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
88,1,5-fluorouracil,5-fluorouracil+irinotecan+leucovorin+nivolumab,2023-01-01,2023-05-27,146,31,3,"5-fluorouracil, irinotecan, leucovorin, nivolumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-20 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+nivolumab', ('administratedate', 'min'): Timestamp('2023-04-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-27 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
88,2,encorafenib,5-fluorouracil+encorafenib+irinotecan+leucovorin,2023-05-27,2023-08-13,78,13,3,"5-fluorouracil, encorafenib, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil+encorafenib', ('administratedate', 'min'): Timestamp('2023-06-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-17 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+encorafenib+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-06-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-13 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+encorafenib+leucovorin', ('administratedate', 'min'): Timestamp('2023-06-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-17 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-05-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-27 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
88,3,regorafenib,regorafenib,2023-08-13,2023-08-13,0,1,0,regorafenib,"[{('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-08-13 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-13 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
88,4,pembrolizumab,pembrolizumab,2023-09-19,2024-03-11,174,10,0,pembrolizumab,"[{('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2023-09-19 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-11 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
88,5,encorafenib,encorafenib,2024-04-15,2024-08-20,127,9,0,encorafenib,"[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2024-04-15 00:00:00'), ('administratedate', 'max'): Timestamp('2024-08-20 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
89,1,5-fluorouracil,5-fluorouracil+panitumumab+pembrolizumab,2023-01-01,2023-01-25,24,9,2,"5-fluorouracil, panitumumab, pembrolizumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+panitumumab', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-25 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+panitumumab+pembrolizumab', ('administratedate', 'min'): Timestamp('2023-01-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-25 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
89,2,aflibercept,aflibercept,2023-03-01,2023-11-01,245,14,0,aflibercept,"[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-03-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-01 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
90,1,5-fluorouracil,5-fluorouracil+aflibercept+capecitabine+leucovorin+oxaliplatin,2023-01-01,2023-06-27,177,37,4,"5-fluorouracil, aflibercept, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+aflibercept+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-03-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-27 00:00:00'), ('regimen_status', 'first'): 'Anti-VEGF Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-02-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-10 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-20 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
90,2,irinotecan,bevacizumab+irinotecan+leucovorin,2023-07-28,2023-11-12,107,9,2,"bevacizumab, irinotecan, leucovorin","[{('regimen', ''): 'bevacizumab+irinotecan', ('administratedate', 'min'): Timestamp('2023-07-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-21 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'bevacizumab+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-10-21 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-12 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'irinotecan', ('administratedate', 'min'): Timestamp('2023-07-28 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-28 00:00:00'), ('regimen_status', 'first'): 'New Line (Topoisomerase Addition)'}]"
90,3,ramucirumab,irinotecan+ramucirumab,2023-11-12,2024-01-12,61,4,1,"irinotecan, ramucirumab","[{('regimen', ''): 'irinotecan+ramucirumab', ('administratedate', 'min'): Timestamp('2023-11-27 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-12 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-11-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-12 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
91,1,capecitabine,capecitabine+oxaliplatin+ramucirumab,2023-01-01,2023-04-01,90,24,2,"capecitabine, oxaliplatin, ramucirumab","[{('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-01 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
91,2,panitumumab,capecitabine+oxaliplatin+panitumumab+ramucirumab,2023-04-01,2023-07-05,95,16,3,"capecitabine, oxaliplatin, panitumumab, ramucirumab","[{('regimen', ''): 'capecitabine+oxaliplatin+panitumumab+ramucirumab', ('administratedate', 'min'): Timestamp('2023-04-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-05 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'oxaliplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-04-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-20 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'oxaliplatin+panitumumab+ramucirumab', ('administratedate', 'min'): Timestamp('2023-04-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-20 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'panitumumab', ('administratedate', 'min'): Timestamp('2023-04-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-01 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
91,3,cetuximab,5-fluorouracil+capecitabine+cetuximab+oxaliplatin+ramucirumab,2023-07-05,2023-10-17,104,16,4,"5-fluorouracil, capecitabine, cetuximab, oxaliplatin, ramucirumab","[{('regimen', ''): '5-fluorouracil+capecitabine+cetuximab+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-09-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-17 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine+cetuximab', ('administratedate', 'min'): Timestamp('2023-08-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'capecitabine+cetuximab+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-08-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-01 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+cetuximab+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-08-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-10 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-07-05 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-05 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
91,4,nivolumab,5-fluorouracil+nivolumab+oxaliplatin+ramucirumab,2023-10-17,2023-11-10,24,4,3,"5-fluorouracil, nivolumab, oxaliplatin, ramucirumab","[{('regimen', ''): '5-fluorouracil+nivolumab+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-11-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-10 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'nivolumab', ('administratedate', 'min'): Timestamp('2023-10-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-17 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'nivolumab+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-11-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-10 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'nivolumab+oxaliplatin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-11-10 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-10 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
91,5,aflibercept,aflibercept,2023-12-24,2024-07-06,195,12,0,aflibercept,"[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-12-24 00:00:00'), ('administratedate', 'max'): Timestamp('2024-07-06 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
91,6,bevacizumab,bevacizumab,2024-07-06,2024-07-06,0,1,0,bevacizumab,"[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2024-07-06 00:00:00'), ('administratedate', 'max'): Timestamp('2024-07-06 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
91,7,ramucirumab,ramucirumab,2024-08-07,2025-06-28,325,19,0,ramucirumab,"[{('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2024-08-07 00:00:00'), ('administratedate', 'max'): Timestamp('2025-06-28 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
91,8,encorafenib,encorafenib,2025-08-13,2025-09-27,45,4,0,encorafenib,"[{('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2025-08-13 00:00:00'), ('administratedate', 'max'): Timestamp('2025-09-27 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
91,9,bevacizumab,bevacizumab+encorafenib,2025-09-27,2026-06-23,269,14,1,"bevacizumab, encorafenib","[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2025-09-27 00:00:00'), ('administratedate', 'max'): Timestamp('2025-09-27 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'bevacizumab+encorafenib', ('administratedate', 'min'): Timestamp('2025-10-17 00:00:00'), ('administratedate', 'max'): Timestamp('2026-06-23 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
92,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin+nivolumab,2023-01-01,2023-05-14,133,31,4,"5-fluorouracil, capecitabine, irinotecan, leucovorin, nivolumab","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-26 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-08 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin+nivolumab', ('administratedate', 'min'): Timestamp('2023-03-08 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-14 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-26 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
92,2,oxaliplatin,5-fluorouracil+irinotecan+leucovorin+oxaliplatin+regorafenib,2023-05-14,2023-10-18,157,26,4,"5-fluorouracil, irinotecan, leucovorin, oxaliplatin, regorafenib","[{('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-06-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-11 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+oxaliplatin+regorafenib', ('administratedate', 'min'): Timestamp('2023-08-11 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-18 00:00:00'), ('regimen_status', 'first'): 'Other Targeted Agent Addition (Within Window)'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-06-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-06 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): '5-fluorouracil+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-06-06 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-06 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-14 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-14 00:00:00'), ('regimen_status', 'first'): 'New Line (Platinum Addition)'}]"
92,3,ramucirumab,5-fluorouracil+irinotecan+leucovorin+ramucirumab,2023-10-18,2023-11-24,37,7,3,"5-fluorouracil, irinotecan, leucovorin, ramucirumab","[{('regimen', ''): '5-fluorouracil+irinotecan+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-10-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-24 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin+ramucirumab', ('administratedate', 'min'): Timestamp('2023-10-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-29 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+ramucirumab', ('administratedate', 'min'): Timestamp('2023-10-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-29 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'ramucirumab', ('administratedate', 'min'): Timestamp('2023-10-18 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-18 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
93,1,capecitabine,capecitabine+encorafenib+oxaliplatin,2023-01-01,2023-01-24,23,9,2,"capecitabine, encorafenib, oxaliplatin","[{('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-24 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
93,2,regorafenib,regorafenib,2023-03-12,2023-08-16,157,10,0,regorafenib,"[{('regimen', ''): 'regorafenib', ('administratedate', 'min'): Timestamp('2023-03-12 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-16 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
93,3,encorafenib,cisplatin+encorafenib+regorafenib,2023-08-16,2024-05-16,274,16,2,"cisplatin, encorafenib, regorafenib","[{('regimen', ''): 'cisplatin+encorafenib+regorafenib', ('administratedate', 'min'): Timestamp('2023-11-22 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-16 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-08-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-16 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'encorafenib+regorafenib', ('administratedate', 'min'): Timestamp('2023-08-29 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-27 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
93,4,pembrolizumab,cisplatin+pembrolizumab,2024-05-16,2024-06-07,22,3,1,"cisplatin, pembrolizumab","[{('regimen', ''): 'cisplatin+pembrolizumab', ('administratedate', 'min'): Timestamp('2024-05-27 00:00:00'), ('administratedate', 'max'): Timestamp('2024-06-07 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'pembrolizumab', ('administratedate', 'min'): Timestamp('2024-05-16 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-16 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}]"
94,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin,2023-01-01,2023-09-28,270,54,3,"5-fluorouracil, capecitabine, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-03-22 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-28 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-22 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
95,1,capecitabine,capecitabine+encorafenib+oxaliplatin,2023-01-01,2023-04-27,116,24,2,"capecitabine, encorafenib, oxaliplatin","[{('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-27 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
95,2,bevacizumab,bevacizumab+capecitabine+encorafenib+oxaliplatin,2023-04-27,2023-07-23,87,19,3,"bevacizumab, capecitabine, encorafenib, oxaliplatin","[{('regimen', ''): 'bevacizumab', ('administratedate', 'min'): Timestamp('2023-04-27 00:00:00'), ('administratedate', 'max'): Timestamp('2023-04-27 00:00:00'), ('regimen_status', 'first'): 'New Line (Second Biologic/Targeted Agent Added)'}, {('regimen', ''): 'bevacizumab+capecitabine', ('administratedate', 'min'): Timestamp('2023-05-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-09 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'bevacizumab+capecitabine+encorafenib+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-23 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'bevacizumab+capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-09 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
95,3,cisplatin,cisplatin+panitumumab,2023-09-08,2024-05-02,237,14,1,"cisplatin, panitumumab","[{('regimen', ''): 'cisplatin', ('administratedate', 'min'): Timestamp('2023-09-08 00:00:00'), ('administratedate', 'max'): Timestamp('2023-09-29 00:00:00'), ('regimen_status', 'first'): 'New Line (Platinum Addition)'}, {('regimen', ''): 'cisplatin+panitumumab', ('administratedate', 'min'): Timestamp('2023-09-29 00:00:00'), ('administratedate', 'max'): Timestamp('2024-05-02 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
96,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin,2023-01-01,2023-06-02,152,27,3,"5-fluorouracil, capecitabine, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-02-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-02 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-02-09 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
96,2,cetuximab,5-fluorouracil+capecitabine+cetuximab+irinotecan+leucovorin,2023-06-02,2023-12-04,185,32,4,"5-fluorouracil, capecitabine, cetuximab, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil+capecitabine+cetuximab+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-08-25 00:00:00'), ('administratedate', 'max'): Timestamp('2023-12-04 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+cetuximab', ('administratedate', 'min'): Timestamp('2023-06-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-17 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+cetuximab+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-06-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-25 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+cetuximab+leucovorin', ('administratedate', 'min'): Timestamp('2023-06-17 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-17 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'cetuximab', ('administratedate', 'min'): Timestamp('2023-06-02 00:00:00'), ('administratedate', 'max'): Timestamp('2023-06-02 00:00:00'), ('regimen_status', 'first'): 'New Line (EGFR Addition/Switch)'}]"
97,1,5-fluorouracil,5-fluorouracil+capecitabine+leucovorin+oxaliplatin,2023-01-01,2023-07-20,200,36,3,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-05-05 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-20 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-05 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}]"
97,2,encorafenib,5-fluorouracil+encorafenib+leucovorin+oxaliplatin,2023-07-20,2023-11-03,106,19,3,"5-fluorouracil, encorafenib, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil+encorafenib', ('administratedate', 'min'): Timestamp('2023-08-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-09 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+encorafenib+leucovorin', ('administratedate', 'min'): Timestamp('2023-08-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-08-09 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): '5-fluorouracil+encorafenib+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-08-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-11-03 00:00:00'), ('regimen_status', 'first'): 'Initial folfox'}, {('regimen', ''): 'encorafenib', ('administratedate', 'min'): Timestamp('2023-07-20 00:00:00'), ('administratedate', 'max'): Timestamp('2023-07-20 00:00:00'), ('regimen_status', 'first'): 'New Line (Other Targeted Agent)'}]"
97,3,irinotecan,5-fluorouracil+capecitabine+irinotecan,2023-12-08,2024-10-16,313,16,2,"5-fluorouracil, capecitabine, irinotecan","[{('regimen', ''): '5-fluorouracil+capecitabine+irinotecan', ('administratedate', 'min'): Timestamp('2024-09-20 00:00:00'), ('administratedate', 'max'): Timestamp('2024-10-16 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine+irinotecan', ('administratedate', 'min'): Timestamp('2024-03-11 00:00:00'), ('administratedate', 'max'): Timestamp('2024-08-31 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'irinotecan', ('administratedate', 'min'): Timestamp('2023-12-08 00:00:00'), ('administratedate', 'max'): Timestamp('2024-01-28 00:00:00'), ('regimen_status', 'first'): 'New Line (Topoisomerase Addition)'}]"
98,1,5-fluorouracil,5-fluorouracil+irinotecan+leucovorin,2023-01-01,2023-01-31,30,15,2,"5-fluorouracil, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-31 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
99,1,5-fluorouracil,5-fluorouracil+capecitabine+irinotecan+leucovorin,2023-01-01,2023-10-03,275,48,3,"5-fluorouracil, capecitabine, irinotecan, leucovorin","[{('regimen', ''): '5-fluorouracil', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): '5-fluorouracil+capecitabine+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-05-16 00:00:00'), ('administratedate', 'max'): Timestamp('2023-10-03 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): '5-fluorouracil+irinotecan+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-16 00:00:00'), ('regimen_status', 'first'): 'Initial folfiri'}, {('regimen', ''): '5-fluorouracil+leucovorin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}]"
99,2,aflibercept,aflibercept,2023-11-09,2024-07-08,242,14,0,aflibercept,"[{('regimen', ''): 'aflibercept', ('administratedate', 'min'): Timestamp('2023-11-09 00:00:00'), ('administratedate', 'max'): Timestamp('2024-07-08 00:00:00'), ('regimen_status', 'first'): 'New Line (Anti-VEGF Addition)'}]"
100,1,capecitabine,capecitabine+oxaliplatin,2023-01-01,2023-03-09,67,10,1,"capecitabine, oxaliplatin","[{('regimen', ''): 'capecitabine', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-01-01 00:00:00'), ('regimen_status', 'first'): 'Initial Drug'}, {('regimen', ''): 'capecitabine+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-01-01 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-09 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}]"
100,2,leucovorin,5-fluorouracil+capecitabine+leucovorin+oxaliplatin,2023-03-09,2024-03-15,372,24,3,"5-fluorouracil, capecitabine, leucovorin, oxaliplatin","[{('regimen', ''): '5-fluorouracil+capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-07-15 00:00:00'), ('administratedate', 'max'): Timestamp('2024-03-15 00:00:00'), ('regimen_status', 'first'): 'Continuation'}, {('regimen', ''): 'capecitabine+leucovorin', ('administratedate', 'min'): Timestamp('2023-03-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-19 00:00:00'), ('regimen_status', 'first'): 'Initial Combination'}, {('regimen', ''): 'capecitabine+leucovorin+oxaliplatin', ('administratedate', 'min'): Timestamp('2023-03-19 00:00:00'), ('administratedate', 'max'): Timestamp('2023-05-26 00:00:00'), ('regimen_status', 'first'): 'Initial capox'}, {('regimen', ''): 'leucovorin', ('administratedate', 'min'): Timestamp('2023-03-09 00:00:00'), ('administratedate', 'max'): Timestamp('2023-03-09 00:00:00'), ('regimen_status', 'first'): 'New Line (Chemo Addition to FLU)'}]"
